<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl" type="text/xsl"?>
<document xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="1fdb4815-2990-4926-ba76-25241810489e"/>
   <code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN PRESCRIPTION DRUG LABEL"/>
   <title>These highlights do not include all the information needed to use PRECEDEX safely and effectively.  See full prescribing information for PRECEDEX.<br/>
      <br/>PRECEDEX<sup>TM</sup> (dexmedetomidine hydrochloride) in sodium chloride injection, for intravenous use<br/>Initial U.S. Approval: 1999</title>
   <effectiveTime value="20250314"/>
   <setId root="92b7ddaa-e45a-4b64-a802-bb5df8771dd6"/>
   <versionNumber value="4"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id extension="141588017" root="1.3.6.1.4.1.519.1"/>
            <name>Hospira, Inc.</name>
            <assignedEntity>
               <assignedOrganization>
                  <assignedEntity>
                     <assignedOrganization>
                        <id extension="030606222" root="1.3.6.1.4.1.519.1"/>
                        <name>Hospira, Inc.</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C25391" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANALYSIS"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0409-4596" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C25391" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANALYSIS"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0409-0155" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C43360" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MANUFACTURE"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0409-4596" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C43360" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MANUFACTURE"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0409-0155" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C84731" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="PACK"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0409-4596" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C84731" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="PACK"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0409-0155" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C84732" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="LABEL"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0409-4596" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C84732" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="LABEL"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0409-0155" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
                  <assignedEntity>
                     <assignedOrganization>
                        <id extension="093132819" root="1.3.6.1.4.1.519.1"/>
                        <name>Hospira, Inc.</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C25391" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANALYSIS"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0409-4596" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C25391" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANALYSIS"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0409-0155" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C43360" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MANUFACTURE"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0409-4596" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C43360" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MANUFACTURE"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0409-0155" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C84731" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="PACK"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0409-4596" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C84731" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="PACK"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0409-0155" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C84732" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="LABEL"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0409-4596" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C84732" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="LABEL"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0409-0155" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
                  <assignedEntity>
                     <assignedOrganization>
                        <id extension="827731089" root="1.3.6.1.4.1.519.1"/>
                        <name>Hospira, Inc.</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C25391" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANALYSIS"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0409-4596" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C25391" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANALYSIS"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0409-0155" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
               </assignedOrganization>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section>
               <id root="c6da0e8b-942f-478b-a84f-64caf4ef43aa"/>
               <code code="48780-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL product data elements section"/>
               <effectiveTime value="20221214"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0409-4596" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Precedex</name>
                        <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>DEXMEDETOMIDINE HYDROCHLORIDE</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIM">
                           <quantity>
                              <numerator unit="ug" value="4"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="1018WH7F9I" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>DEXMEDETOMIDINE HYDROCHLORIDE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="67VB76HONO" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>DEXMEDETOMIDINE</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator unit="mg" value="9"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="451W47IQ8X" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM CHLORIDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>WATER</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator unit="mL" value="50"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code code="0409-4596-01" codeSystem="2.16.840.1.113883.6.69"/>
                              <formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="20"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0409-4596-20" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C53438" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TRAY"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20230103"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic classCode="OBS">
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CE"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="NDA021038" root="2.16.840.1.113883.3.150"/>
                           <code code="C73594" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="NDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20230103"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INTRAVENOUS"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0409-0155" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Precedex</name>
                        <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>DEXMEDETOMIDINE HYDROCHLORIDE</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIM">
                           <quantity>
                              <numerator unit="ug" value="4"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="1018WH7F9I" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>DEXMEDETOMIDINE HYDROCHLORIDE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="67VB76HONO" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>DEXMEDETOMIDINE</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator unit="mg" value="9"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="451W47IQ8X" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM CHLORIDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>WATER</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator unit="mL" value="100"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code code="0409-0155-01" codeSystem="2.16.840.1.113883.6.69"/>
                              <formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="10"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0409-0155-02" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C53438" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TRAY"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20230103"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic classCode="OBS">
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CE"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="NDA021038" root="2.16.840.1.113883.3.150"/>
                           <code code="C73594" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="NDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20230103"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INTRAVENOUS"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
            </section>
         </component>
         <component>
            <section ID="ID_707A8EEA-83BC-41B4-A211-C94721B2C120">
               <id root="3609010f-3193-407e-b5bd-28b6d6fb7f26"/>
               <code code="43683-2" codeSystem="2.16.840.1.113883.6.1" displayName="RECENT MAJOR CHANGES SECTION"/>
               <effectiveTime value="20221212"/>
               <excerpt>
                  <highlight>
                     <text>
                        <table styleCode="Noautorules" width="100%">
                           <col width="50%"/>
                           <col width="50%"/>
                           <tbody>
                              <tr>
                                 <td valign="top">
                                    <paragraph>Indication and Usage, Procedural Sedation (<linkHtml href="#ID_a11d225b-b7e0-441a-a1c2-dde9b1c6484f">1.2</linkHtml>)</paragraph>
                                 </td>
                                 <td align="center" valign="top">
                                    <paragraph>12/2022</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td valign="top">
                                    <paragraph>Dosage and Administration, Recommended Dosage (<linkHtml href="#ID_8be24d35-77bd-487e-83d0-7d04dd1ad70b">2.2</linkHtml>)</paragraph>
                                 </td>
                                 <td align="center" valign="top">
                                    <paragraph>12/2022</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td valign="top">
                                    <paragraph>Dosage and Administration, Preparation of Solution (<linkHtml href="#ID_6eb1ee8f-8ea8-4d29-a092-d19ea6306472">2.4</linkHtml>)</paragraph>
                                 </td>
                                 <td align="center" valign="top">
                                    <paragraph>08/2022</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td valign="top">
                                    <paragraph>Warnings and Precautions, Withdrawal (<linkHtml href="#ID_b047b720-2925-4e4e-b30c-b8e1f3879bfd">5.5</linkHtml>)</paragraph>
                                 </td>
                                 <td align="center" valign="top">
                                    <paragraph>12/2022</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td valign="top">
                                    <paragraph>Warnings and Precautions, Hyperthermia or Pyrexia (<linkHtml href="#ID_c7adf5bb-3c6b-4a24-aa28-27fc6d5b16d7">5.7</linkHtml>)</paragraph>
                                 </td>
                                 <td align="center" valign="top">
                                    <paragraph>08/2022</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="ID_7AF867FA-EE7A-415E-9151-7CCE4478DDA4">
               <id root="3ee79a7f-44c9-4c1b-96f1-48be7de17e53"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>1 INDICATIONS AND USAGE </title>
               <effectiveTime value="20221201"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>PRECEDEX is a alpha<sub>2</sub>-adrenergic receptor agonist indicated for:</paragraph>
                        <list listType="unordered">
                           <item>
                              <caption>•</caption>Sedation of initially intubated and mechanically ventilated adult patients during treatment in an intensive care setting. Administer PRECEDEX by continuous infusion not to exceed 24 hours. (<linkHtml href="#ID_79717fbb-f896-43c1-9f68-644da538a029">1.1</linkHtml>)</item>
                           <item>
                              <caption>•</caption>Sedation of non-intubated adult patients prior to and/or during surgical and other procedures. (<linkHtml href="#ID_a11d225b-b7e0-441a-a1c2-dde9b1c6484f">1.2</linkHtml>)</item>
                           <item>
                              <caption>•</caption>Sedation of non-intubated pediatric patients aged 1 month to less than 18 years prior to and during non-invasive procedures. (<linkHtml href="#ID_a11d225b-b7e0-441a-a1c2-dde9b1c6484f">1.2</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="ID_79717fbb-f896-43c1-9f68-644da538a029">
                     <id root="a7359dc5-24ba-496f-9011-1211cac307ad"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>1.1	Intensive Care Unit Sedation </title>
                     <text>
                        <paragraph>PRECEDEX is indicated for sedation of initially intubated and mechanically ventilated adult patients during treatment in an intensive care setting. PRECEDEX should be administered by continuous infusion not to exceed 24 hours.</paragraph>
                        <paragraph>PRECEDEX has been continuously infused in mechanically ventilated adult patients prior to extubation, during extubation, and post-extubation. It is not necessary to discontinue PRECEDEX prior to extubation.</paragraph>
                     </text>
                     <effectiveTime value="20221201"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_a11d225b-b7e0-441a-a1c2-dde9b1c6484f">
                     <id root="2cb4f43d-e31d-42e5-bb7d-c15525d768a9"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>1.2	Procedural Sedation </title>
                     <text>
                        <paragraph>PRECEDEX is indicated for sedation of non-intubated adult patients prior to and/or during surgical and other procedures.</paragraph>
                        <paragraph>
                           <content styleCode="xmChange">PRECEDEX is indicated for sedation of non-intubated pediatric patients aged 1 month to less than 18 years prior to and during non-invasive procedures.</content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20221201"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_35B02332-CBC6-4241-B5D2-24D4495C5B46">
               <id root="c7b9de51-05e8-4983-b60e-ac04f842fbb9"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>2 DOSAGE AND ADMINISTRATION </title>
               <effectiveTime value="20221212"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered">
                           <item>
                              <caption>•</caption>Individualize and titrate PRECEDEX dosing to desired clinical effect. (<linkHtml href="#ID_b9b8884e-5967-4194-914b-699f496b89ec">2.1</linkHtml>)</item>
                           <item>
                              <caption>•</caption>Administer PRECEDEX using a controlled infusion device. (<linkHtml href="#ID_b9b8884e-5967-4194-914b-699f496b89ec">2.1</linkHtml>)</item>
                           <item>
                              <caption>•</caption>The 200 mcg/50 mL, and 400 mcg/100 mL single-dose bottles do not require further dilution prior to administration. (<linkHtml href="#ID_6eb1ee8f-8ea8-4d29-a092-d19ea6306472">2.4</linkHtml>)</item>
                           <item>
                              <caption>•</caption>
                              <content styleCode="underline">For Adult Intensive Care Unit Sedation</content>: Initiate at one mcg/kg over 10 <content styleCode="italics">
                                 <content styleCode="underline">minutes</content>
                              </content>, followed by a maintenance infusion of 0.2 to 0.7 mcg/kg/<content styleCode="italics">
                                 <content styleCode="underline">hour</content>
                              </content>. (<linkHtml href="#ID_8be24d35-77bd-487e-83d0-7d04dd1ad70b">2.2</linkHtml>)</item>
                           <item>
                              <caption>•</caption>
                              <content styleCode="underline">For Adult Procedural Sedation</content>: Initiate at one mcg/kg over 10 <content styleCode="italics">
                                 <content styleCode="underline">minutes</content>
                              </content>, followed by a maintenance infusion initiated at 0.6 mcg/kg/<content styleCode="italics">
                                 <content styleCode="underline">hour</content>
                              </content> and titrated to achieve desired clinical effect with doses ranging from 0.2 to 1 mcg/kg/<content styleCode="italics">
                                 <content styleCode="underline">hour</content>
                              </content>. (<linkHtml href="#ID_8be24d35-77bd-487e-83d0-7d04dd1ad70b">2.2</linkHtml>)</item>
                           <item>
                              <caption>•</caption>
                              <content styleCode="underline">For Sedation of Pediatric Patients During Non-invasive Procedures</content>: Patients 1 month to less than 2 years old initiate at 1.5 mcg/kg over 10 <content styleCode="italics">
                                 <content styleCode="underline">minutes</content>
                              </content> followed by a maintenance infusion of 1.5 mcg/kg/<content styleCode="italics">
                                 <content styleCode="underline">hour</content>
                              </content> and titrated to achieve desired clinical effect with dosage ranging from 0.5 to 1.5 mcg/kg/<content styleCode="italics">
                                 <content styleCode="underline">hour</content>
                              </content>; patients 2 to less than 18 years old initiate at 2.0 mcg/kg over 10 <content styleCode="italics">
                                 <content styleCode="underline">minutes</content>
                              </content> followed by a maintenance infusion of 1.5 mcg/kg/<content styleCode="italics">
                                 <content styleCode="underline">hour</content>
                              </content> and titrated to achieve desired clinical effect with dosage ranging from 0.5 to 1.5 mcg/kg/<content styleCode="italics">
                                 <content styleCode="underline">hour</content>
                              </content>. (<linkHtml href="#ID_8be24d35-77bd-487e-83d0-7d04dd1ad70b">2.2</linkHtml>)</item>
                           <item>
                              <caption>•</caption>
                              <content styleCode="underline">Alternative Doses</content>: Recommended for patients over 65 years of age and awake fiberoptic intubation patients. (<linkHtml href="#ID_8be24d35-77bd-487e-83d0-7d04dd1ad70b">2.2</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="ID_b9b8884e-5967-4194-914b-699f496b89ec">
                     <id root="8fa65d96-5a8a-4726-b5af-bf8ecccb8eb2"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.1	Administration Instructions </title>
                     <text>
                        <list listType="unordered">
                           <item>
                              <caption>•</caption>PRECEDEX dosing should be individualized and titrated to desired clinical response.</item>
                           <item>
                              <caption>•</caption>PRECEDEX is not indicated for infusions lasting longer than 24 hours.</item>
                           <item>
                              <caption>•</caption>PRECEDEX should be administered using a controlled infusion device.</item>
                        </list>
                     </text>
                     <effectiveTime value="20221201"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_8be24d35-77bd-487e-83d0-7d04dd1ad70b">
                     <id root="60274481-3d86-4588-9de0-d185e2215558"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.2	Recommended Dosage </title>
                     <text>
                        <table width="100%">
                           <caption>Table 1: Recommended Dosage in Adult Patients</caption>
                           <col width="27%"/>
                           <col width="73%"/>
                           <tbody>
                              <tr>
                                 <td styleCode="Rrule Botrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">INDICATION</content>
                                    </paragraph>
                                 </td>
                                 <td styleCode="Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">DOSAGE AND ADMINISTRATION</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="middle">
                                    <paragraph>
                                       <content styleCode="bold">Initiation of Intensive Care Unit Sedation</content>
                                    </paragraph>
                                 </td>
                                 <td styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="underline">For adult patients: </content>a loading infusion of one mcg/kg over 10 <content styleCode="italics">
                                          <content styleCode="underline">minutes</content>
                                       </content>.</paragraph>
                                    <paragraph>
                                       <content styleCode="underline">For adult patients being converted from alternate sedative therapy:</content> a loading dose may not be required.</paragraph>
                                    <paragraph>
                                       <content styleCode="underline">For patients over 65 years of age:</content> Consider a dose reduction <content styleCode="italics">[see <linkHtml href="#ID_58E58B61-CA0C-4C22-9F96-DC0FFFD6E213">Use in Specific Populations (8.5)</linkHtml>]</content>.</paragraph>
                                    <paragraph>
                                       <content styleCode="underline">For adult patients with impaired hepatic function:</content> Consider a dose reduction <content styleCode="italics">[see <linkHtml href="#ID_668886b6-74b7-4db8-8215-95af554384a5">Use in Specific Populations (8.6)</linkHtml>, <linkHtml href="#ID_5427497F-654A-4F81-B0AB-2756258A55DE">Clinical Pharmacology (12.3)</linkHtml>]</content>.</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="middle">
                                    <paragraph>
                                       <content styleCode="bold">Maintenance of Intensive Care Unit Sedation</content>
                                    </paragraph>
                                 </td>
                                 <td styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="underline">For adult patients:</content> a maintenance infusion of 0.2 to 0.7 mcg/kg/<content styleCode="italics">
                                          <content styleCode="underline">hour</content>
                                       </content>. The rate of the maintenance infusion should be adjusted to achieve the desired level of sedation.</paragraph>
                                    <paragraph>
                                       <content styleCode="underline">For patients over 65 years of age:</content> Consider a dose reduction <content styleCode="italics">[see <linkHtml href="#ID_58E58B61-CA0C-4C22-9F96-DC0FFFD6E213">Use in Specific Populations (8.5)</linkHtml>]</content>.</paragraph>
                                    <paragraph>
                                       <content styleCode="underline">For adult patients with impaired hepatic function:</content> Consider a dose reduction <content styleCode="italics">[see <linkHtml href="#ID_668886b6-74b7-4db8-8215-95af554384a5">Use in Specific Populations (8.6)</linkHtml>, <linkHtml href="#ID_5427497F-654A-4F81-B0AB-2756258A55DE">Clinical Pharmacology (12.3)</linkHtml>]</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="middle">
                                    <paragraph>
                                       <content styleCode="bold">Initiation of Procedural Sedation</content>
                                    </paragraph>
                                 </td>
                                 <td styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="underline">For adult patients:</content> a loading infusion of one mcg/kg over 10 <content styleCode="italics">
                                          <content styleCode="underline">minutes</content>
                                       </content>. For less invasive procedures such as ophthalmic surgery, a loading infusion of 0.5 mcg/kg given over 10 <content styleCode="italics">
                                          <content styleCode="underline">minutes</content>
                                       </content> may be suitable.</paragraph>
                                    <paragraph>
                                       <content styleCode="underline">For awake fiberoptic intubation in adult patients:</content> a loading infusion of one mcg/kg over 10 <content styleCode="italics">
                                          <content styleCode="underline">minutes</content>
                                       </content>.</paragraph>
                                    <paragraph>
                                       <content styleCode="underline">For patients over 65 years of age:</content> a loading infusion of 0.5 mcg/kg over 10 <content styleCode="italics">
                                          <content styleCode="underline">minutes</content> [see <linkHtml href="#ID_58E58B61-CA0C-4C22-9F96-DC0FFFD6E213">Use in Specific Populations (8.5)</linkHtml>]</content>.</paragraph>
                                    <paragraph>
                                       <content styleCode="underline">For adult patients with impaired hepatic function:</content> Consider a dose reduction <content styleCode="italics">[see <linkHtml href="#ID_668886b6-74b7-4db8-8215-95af554384a5">Use in Specific Populations (8.6)</linkHtml>, <linkHtml href="#ID_5427497F-654A-4F81-B0AB-2756258A55DE">Clinical Pharmacology (12.3)</linkHtml>]</content>.</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule Toprule " valign="middle">
                                    <paragraph>
                                       <content styleCode="bold">Maintenance of Procedural Sedation</content>
                                    </paragraph>
                                 </td>
                                 <td styleCode="Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="underline">For adult patients:</content> the maintenance infusion is generally initiated at 0.6 mcg/kg/<content styleCode="italics">
                                          <content styleCode="underline">hour</content>
                                       </content> and titrated to achieve desired clinical effect with doses ranging from 0.2 to 1 mcg/kg/<content styleCode="italics">
                                          <content styleCode="underline">hour</content>
                                       </content>. Adjust the rate of the maintenance infusion to achieve the targeted level of sedation.</paragraph>
                                    <paragraph>
                                       <content styleCode="underline">For awake fiberoptic intubation in adult patients:</content> a maintenance infusion of 0.7 mcg/kg/<content styleCode="italics">
                                          <content styleCode="underline">hour</content>
                                       </content> is recommended until the endotracheal tube is secured.</paragraph>
                                    <paragraph>
                                       <content styleCode="underline">For patients over 65 years of age:</content> Consider a dose reduction <content styleCode="italics">[see <linkHtml href="#ID_58E58B61-CA0C-4C22-9F96-DC0FFFD6E213">Use in Specific Populations (8.5)</linkHtml>]</content>.</paragraph>
                                    <paragraph>
                                       <content styleCode="underline">For adult patients with impaired hepatic function:</content> Consider a dose reduction <content styleCode="italics">[see <linkHtml href="#ID_668886b6-74b7-4db8-8215-95af554384a5">Use in Specific Populations (8.6)</linkHtml>, <linkHtml href="#ID_5427497F-654A-4F81-B0AB-2756258A55DE">Clinical Pharmacology (12.3)</linkHtml>]</content>.</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <table ID="_RefID0EQTAE" width="100%">
                           <caption>Table 2: Recommended Dosage in Pediatric Patients</caption>
                           <col width="27%"/>
                           <col width="73%"/>
                           <tbody>
                              <tr styleCode="Toprule">
                                 <td styleCode="Rrule Botrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="xmChange">
                                          <content styleCode="bold">INDICATION</content>
                                       </content>
                                    </paragraph>
                                 </td>
                                 <td styleCode="Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="xmChange">
                                          <content styleCode="bold">DOSAGE AND ADMINISTRATION</content>
                                       </content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="xmChange">
                                          <content styleCode="bold">Initiation of Sedation During Non‑invasive Procedures</content>
                                       </content>
                                    </paragraph>
                                 </td>
                                 <td styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="xmChange">
                                          <content styleCode="underline">For pediatric patients:</content>
                                       </content>
                                    </paragraph>
                                    <list listType="unordered">
                                       <item>
                                          <caption>•</caption>
                                          <content styleCode="xmChange">1 month to less than 2 years: a loading infusion of 1.5 mcg/kg over 10 <content styleCode="underline">minutes</content>.</content>
                                       </item>
                                       <item>
                                          <caption>•</caption>
                                          <content styleCode="xmChange">2 to less than 18 years: a loading infusion of 2 mcg/kg over 10 <content styleCode="underline">minutes</content>.</content>
                                       </item>
                                    </list>
                                    <paragraph>
                                       <content styleCode="xmChange">Consider a reduction in dosage if clinically indicated.</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Rrule Botrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="xmChange">
                                          <content styleCode="bold">Maintenance of Sedation During Non-invasive Procedures</content>
                                       </content>
                                    </paragraph>
                                 </td>
                                 <td styleCode="Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="xmChange">
                                          <content styleCode="underline">For pediatric patients:</content>
                                       </content>
                                    </paragraph>
                                    <list listType="unordered">
                                       <item>
                                          <caption>•</caption>
                                          <content styleCode="xmChange">1 month to less than 18 years: the maintenance infusion is generally initiated at 1.5 mcg/kg/<content styleCode="italics">hour </content>and titrated to achieve desired clinical effect with dosage ranging from 0.5 to 1.5 mcg/kg/<content styleCode="italics">
                                                <content styleCode="underline">hour</content>
                                             </content>.</content>
                                       </item>
                                    </list>
                                    <paragraph>
                                       <content styleCode="xmChange">As clinically warranted, titrate the maintenance dose to individual patient clinical response.</content>
                                    </paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                     </text>
                     <effectiveTime value="20221212"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_419377a3-7a63-4deb-9e0e-9ed785cb3176">
                     <id root="27cde068-e09c-467d-8d62-d4811a6dba49"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.3	Dosage Adjustment </title>
                     <text>
                        <paragraph>Due to possible pharmacodynamic interactions, a reduction in dosage of PRECEDEX or other concomitant anesthetics, sedatives, hypnotics or opioids may be required when co-administered <content styleCode="italics">[see <linkHtml href="#ID_254ee44e-44fd-4f86-9f26-b1c4773a3cf2">Drug Interactions (7.1)</linkHtml>]</content>.</paragraph>
                        <paragraph>Dosage reductions may need to be considered for adult patients with hepatic impairment, and geriatric patients <content styleCode="italics">[see <linkHtml href="#ID_24d08c94-822b-421c-8fba-aadac1eab6c9">Warnings and Precautions (5.8)</linkHtml>, <linkHtml href="#ID_668886b6-74b7-4db8-8215-95af554384a5">Use in Specific Populations (8.6)</linkHtml>, <linkHtml href="#ID_5427497F-654A-4F81-B0AB-2756258A55DE">Clinical Pharmacology (12.3)</linkHtml>]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20221201"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_6eb1ee8f-8ea8-4d29-a092-d19ea6306472">
                     <id root="6eb1ee8f-8ea8-4d29-a092-d19ea6306472"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.4	Preparation of Solution </title>
                     <text>
                        <paragraph>Strict aseptic technique must always be maintained during handling of PRECEDEX.</paragraph>
                        <paragraph>Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. <content styleCode="xmChange">Do not use if product is discolored or if precipitate matter is present.</content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="underline">PRECEDEX in 0.9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg/mL) and 400 mcg/100 mL (4 mcg/mL)</content>
                        </paragraph>
                        <paragraph>PRECEDEX in 0.9% Sodium Chloride Injection is supplied in glass containers containing a premixed, ready to use dexmedetomidine hydrochloride solution in 0.9% sodium chloride in water. No further dilution of this preparation is necessary.</paragraph>
                     </text>
                     <effectiveTime value="20221214"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_210b5a08-dc3d-4555-a16e-9aa2494c045e">
                     <id root="210b5a08-dc3d-4555-a16e-9aa2494c045e"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.5	Administration with Other Fluids </title>
                     <text>
                        <paragraph>PRECEDEX infusion should not be co-administered through the same intravenous catheter with blood or plasma because physical compatibility has not been established.</paragraph>
                        <paragraph>PRECEDEX has been shown to be incompatible when administered with the following drugs: amphotericin B, diazepam.</paragraph>
                        <paragraph>PRECEDEX has been shown to be compatible when administered with the following intravenous fluids:</paragraph>
                        <list listType="unordered">
                           <item>
                              <caption>•</caption>0.9% sodium chloride in water</item>
                           <item>
                              <caption>•</caption>5% dextrose in water</item>
                           <item>
                              <caption>•</caption>20% mannitol</item>
                           <item>
                              <caption>•</caption>Lactated Ringer’s solution</item>
                           <item>
                              <caption>•</caption>100 mg/mL magnesium sulfate solution</item>
                           <item>
                              <caption>•</caption>0.3% potassium chloride solution</item>
                        </list>
                     </text>
                     <effectiveTime value="20221214"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_f344210d-df34-4efd-ad6d-22b3390812b8">
                     <id root="f344210d-df34-4efd-ad6d-22b3390812b8"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.6	Compatibility with Natural Rubber </title>
                     <text>
                        <paragraph>Compatibility studies have demonstrated the potential for absorption of PRECEDEX to some types of natural rubber. Although PRECEDEX is dosed to effect, it is advisable to use administration components made with synthetic or coated natural rubber gaskets.</paragraph>
                     </text>
                     <effectiveTime value="20221214"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_2CB3ABA3-819D-4926-AAE5-501FA0E4A45C">
               <id root="ad5db8de-9612-4fdc-b35d-1dd20a1a73b4"/>
               <code code="43678-2" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE FORMS &amp; STRENGTHS SECTION"/>
               <title>3 DOSAGE FORMS AND STRENGTHS </title>
               <text>
                  <paragraph>PRECEDEX (dexmedetomidine hydrochloride) in 0.9% sodium chloride injection is a clear and colorless solution, ready to use. It is available as:</paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>•</caption>PRECEDEX 200 mcg/50 mL (4 mcg/mL) single-dose glass bottle.</item>
                     <item>
                        <caption>•</caption>PRECEDEX 400 mcg/100 mL (4 mcg/mL) single-dose glass bottle.</item>
                  </list>
               </text>
               <effectiveTime value="20221214"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>PRECEDEX in 0.9% Sodium Chloride Injection, 200 mcg/50 mL and 400 mcg/100 mL (4 mcg/mL) in a single-dose glass bottle. Ready to use. (<linkHtml href="#ID_2CB3ABA3-819D-4926-AAE5-501FA0E4A45C">3</linkHtml>)</paragraph>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="ID_11847C92-3871-43B8-8354-64815B0E8C23">
               <id root="27d2c4a9-9224-4cf1-91cd-9b9f0c31c529"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title>4 CONTRAINDICATIONS </title>
               <text>
                  <paragraph>None.</paragraph>
               </text>
               <effectiveTime value="20221214"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>None. (<linkHtml href="#ID_11847C92-3871-43B8-8354-64815B0E8C23">4</linkHtml>)</paragraph>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="ID_AD650C61-C208-43C5-B65A-198A1098B9A7">
               <id root="8a160a41-f0e5-4591-9965-5969f109d161"/>
               <code code="43685-7" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS AND PRECAUTIONS SECTION"/>
               <title>5 WARNINGS AND PRECAUTIONS </title>
               <effectiveTime value="20221212"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered">
                           <item>
                              <caption>•</caption>
                              <content styleCode="underline">Monitoring</content>: Continuously monitor patients while receiving PRECEDEX. (<linkHtml href="#ID_2707a00c-2251-42b0-8586-17c19b985dfb">5.1</linkHtml>)</item>
                           <item>
                              <caption>•</caption>
                              <content styleCode="underline">Bradycardia and Sinus Arrest</content>: Have occurred in young healthy volunteers with high vagal tone or with different routes of administration, e.g., rapid intravenous or bolus administration. (<linkHtml href="#ID_000c8ebe-99fe-4683-9f3b-7c5d6ce8c381">5.2</linkHtml>)</item>
                           <item>
                              <caption>•</caption>
                              <content styleCode="underline">Hypotension and Bradycardia</content>: May necessitate medical intervention. May be more pronounced in patients with hypovolemia, diabetes mellitus, or chronic hypertension, and in the elderly. Use with caution in patients with advanced heart block or severe ventricular dysfunction. (<linkHtml href="#ID_000c8ebe-99fe-4683-9f3b-7c5d6ce8c381">5.2</linkHtml>)</item>
                           <item>
                              <caption>•</caption>
                              <content styleCode="underline">Co-administration with Other Vasodilators or Negative Chronotropic Agents</content>: Use with caution due to additive pharmacodynamic effects. (<linkHtml href="#ID_000c8ebe-99fe-4683-9f3b-7c5d6ce8c381">5.2</linkHtml>)</item>
                           <item>
                              <caption>•</caption>
                              <content styleCode="underline">Transient Hypertension</content>: Observed primarily during the loading dose. Consider reduction in loading infusion rate. (<linkHtml href="#ID_c65dc109-c8ac-4cf8-b3c0-838f08a62600">5.3</linkHtml>)</item>
                           <item>
                              <caption>•</caption>
                              <content styleCode="underline">Arousability</content>: Patients can become aroused/alert with stimulation; this alone should not be considered as lack of efficacy. (<linkHtml href="#ID_0e8ba465-9b2c-49a0-bbb8-b5f514fcd853">5.4</linkHtml>)</item>
                           <item>
                              <caption>•</caption>
                              <content styleCode="underline">Tolerance and Tachyphylaxis</content>: Prolonged exposure to dexmedetomidine beyond 24 hours may be associated with tolerance and tachyphylaxis and a dose-related increase in adverse events. (<linkHtml href="#ID_7bd4f85c-0eee-4ad0-b016-860420e6bf3e">5.6</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="ID_2707a00c-2251-42b0-8586-17c19b985dfb">
                     <id root="2707a00c-2251-42b0-8586-17c19b985dfb"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.1	Drug Administration </title>
                     <text>
                        <paragraph>PRECEDEX should be administered only by persons skilled in the management of patients in the intensive care or operating room setting. Due to the known pharmacological effects of PRECEDEX, patients should be continuously monitored while receiving PRECEDEX.</paragraph>
                     </text>
                     <effectiveTime value="20221214"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_000c8ebe-99fe-4683-9f3b-7c5d6ce8c381">
                     <id root="000c8ebe-99fe-4683-9f3b-7c5d6ce8c381"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.2	Hypotension, Bradycardia, and Sinus Arrest </title>
                     <text>
                        <paragraph>Clinically significant episodes of bradycardia and sinus arrest have been reported with PRECEDEX administration in young, healthy adult volunteers with high vagal tone or with different routes of administration including rapid intravenous or bolus administration.</paragraph>
                        <paragraph>Reports of hypotension and bradycardia have been associated with PRECEDEX infusion. Some of these cases have resulted in fatalities. If medical intervention is required, treatment may include decreasing or stopping the infusion of PRECEDEX, increasing the rate of intravenous fluid administration, elevation of the lower extremities, and use of pressor agents. Because PRECEDEX has the potential to augment bradycardia induced by vagal stimuli, clinicians should be prepared to intervene. The intravenous administration of anticholinergic agents (e.g., glycopyrrolate, atropine) should be considered to modify vagal tone. In clinical trials, glycopyrrolate or atropine were effective in the treatment of most episodes of PRECEDEX-induced bradycardia. However, in some patients with significant cardiovascular dysfunction, more advanced resuscitative measures were required.</paragraph>
                        <paragraph>Caution should be exercised when administering PRECEDEX to patients with advanced heart block and/or severe ventricular dysfunction. Because PRECEDEX decreases sympathetic nervous system activity, hypotension and/or bradycardia may be expected to be more pronounced in patients with hypovolemia, diabetes mellitus, or chronic hypertension and in elderly patients.</paragraph>
                        <paragraph>In clinical trials where other vasodilators or negative chronotropic agents were co-administered with PRECEDEX an additive pharmacodynamic effect was not observed. Nonetheless, caution should be used when such agents are administered concomitantly with PRECEDEX.</paragraph>
                     </text>
                     <effectiveTime value="20221214"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_c65dc109-c8ac-4cf8-b3c0-838f08a62600">
                     <id root="c65dc109-c8ac-4cf8-b3c0-838f08a62600"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.3	Transient Hypertension </title>
                     <text>
                        <paragraph>Transient hypertension has been observed primarily during the loading dose in association with the initial peripheral vasoconstrictive effects of PRECEDEX. Treatment of the transient hypertension has generally not been necessary, although reduction of the loading infusion rate may be desirable.</paragraph>
                     </text>
                     <effectiveTime value="20221214"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_0e8ba465-9b2c-49a0-bbb8-b5f514fcd853">
                     <id root="0e8ba465-9b2c-49a0-bbb8-b5f514fcd853"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.4	Arousability </title>
                     <text>
                        <paragraph>Some patients receiving PRECEDEX have been observed to be arousable and alert when stimulated. This alone should not be considered as evidence of lack of efficacy in the absence of other clinical signs and symptoms.</paragraph>
                     </text>
                     <effectiveTime value="20221214"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_b047b720-2925-4e4e-b30c-b8e1f3879bfd">
                     <id root="3a89e280-1877-46d2-a383-ce0e114b135b"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.5	Withdrawal </title>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Intensive Care Unit Sedation</content>
                        </paragraph>
                        <paragraph>With administration up to 7 days, regardless of dose, 12 (5%) PRECEDEX adult subjects experienced at least 1 event related to withdrawal within the first 24 hours after discontinuing study drug and 7 (3%) PRECEDEX adult subjects experienced at least 1 event 24 to 48 hours after end of study drug. The most common events were nausea, vomiting, and agitation <content styleCode="italics">[see <linkHtml href="#ID_b91b0be6-1ca3-468d-a2fe-c3f1e6176758">Adverse Reactions (6.1)</linkHtml>]</content>.</paragraph>
                        <paragraph>In adult subjects, tachycardia and hypertension requiring intervention in the 48 hours following study drug discontinuation occurred at frequencies of &lt;5%.</paragraph>
                        <paragraph>
                           <content styleCode="underline">Procedural Sedation</content>
                        </paragraph>
                        <paragraph>In adult subjects, withdrawal symptoms were not seen after discontinuation of short-term infusions of PRECEDEX (&lt;6 hours).</paragraph>
                        <paragraph>In pediatric patients, mild transient withdrawal symptoms of emergence delirium or agitation were seen after discontinuation of short‑term infusions of PRECEDEX (&lt;2 hours) [see <linkHtml href="#ID_b91b0be6-1ca3-468d-a2fe-c3f1e6176758">Adverse Reactions (6.1)</linkHtml>].</paragraph>
                     </text>
                     <effectiveTime value="20221212"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_7bd4f85c-0eee-4ad0-b016-860420e6bf3e">
                     <id root="efcb3162-d78d-4df8-befa-5db552895322"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.6	Tolerance and Tachyphylaxis </title>
                     <text>
                        <paragraph>Use of dexmedetomidine beyond 24 hours has been associated with tolerance and tachyphylaxis and a dose-related increase in adverse reactions <content styleCode="italics">[see <linkHtml href="#ID_b91b0be6-1ca3-468d-a2fe-c3f1e6176758">Adverse Reactions (6.1)</linkHtml>]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20221201"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_c7adf5bb-3c6b-4a24-aa28-27fc6d5b16d7">
                     <id root="c7adf5bb-3c6b-4a24-aa28-27fc6d5b16d7"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.7	Hyperthermia or Pyrexia </title>
                     <text>
                        <paragraph>
                           <content styleCode="xmChange">PRECEDEX may induce hyperthermia or pyrexia, which may be resistant to traditional cooling methods, such as administration of cooled intravenous fluids and antipyretic medications. Discontinue PRECEDEX if drug-related hyperthermia or pyrexia is suspected and monitor patients until body temperature normalizes.</content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20221214"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_24d08c94-822b-421c-8fba-aadac1eab6c9">
                     <id root="28d4f89d-8a7e-482a-81e0-f557977bb9ad"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.8	Hepatic Impairment </title>
                     <text>
                        <paragraph>Since PRECEDEX clearance decreases with severity of hepatic impairment, dose reduction should be considered in patients with impaired hepatic function <content styleCode="italics">[see <linkHtml href="#ID_8be24d35-77bd-487e-83d0-7d04dd1ad70b">Dosage and Administration (2.2</linkHtml>, <linkHtml href="#ID_419377a3-7a63-4deb-9e0e-9ed785cb3176">2.3</linkHtml>)]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20221201"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_19444EE5-4F0B-43FE-8F1B-3BF263909144">
               <id root="f5f58aa4-7f2e-4ca5-8981-98a65acd3a5e"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title>6 ADVERSE REACTIONS </title>
               <text>
                  <paragraph>The following clinically significant adverse reactions are described elsewhere in the labeling:</paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>•</caption>Hypotension, bradycardia and sinus arrest <content styleCode="italics">[see <linkHtml href="#ID_000c8ebe-99fe-4683-9f3b-7c5d6ce8c381">Warnings and Precautions (5.2)</linkHtml>]</content>
                     </item>
                     <item>
                        <caption>•</caption>Transient hypertension <content styleCode="italics">[see <linkHtml href="#ID_c65dc109-c8ac-4cf8-b3c0-838f08a62600">Warnings and Precautions (5.3)</linkHtml>]</content>
                     </item>
                  </list>
               </text>
               <effectiveTime value="20221212"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered">
                           <item>
                              <caption>•</caption>The most common adverse reactions (incidence &gt;2%) in adults are hypotension, bradycardia, and dry mouth. (<linkHtml href="#ID_b91b0be6-1ca3-468d-a2fe-c3f1e6176758">6.1</linkHtml>)</item>
                           <item>
                              <caption>•</caption>The most common adverse reactions (incidence &gt;5%) in pediatric patients aged 1 month to less than 17 years are bradypnea, bradycardia, hypertension, and hypotension. (<linkHtml href="#ID_b91b0be6-1ca3-468d-a2fe-c3f1e6176758">6.1</linkHtml>)</item>
                           <item>
                              <caption>•</caption>Adverse reactions in adults, associated with infusions &gt;24 hours in duration include ARDS, respiratory failure, and agitation. (<linkHtml href="#ID_b91b0be6-1ca3-468d-a2fe-c3f1e6176758">6.1</linkHtml>)</item>
                        </list>
                        <paragraph>
                           <content styleCode="bold">To report SUSPECTED ADVERSE REACTIONS, contact Hospira, Inc. at 1-800-441-4100, or FDA at 1-800-FDA-1088 or <content styleCode="italics">
                                 <linkHtml href="http://www.fda.gov/medwatch">www.fda.gov/medwatch.</linkHtml>
                              </content>
                           </content>
                        </paragraph>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="ID_b91b0be6-1ca3-468d-a2fe-c3f1e6176758">
                     <id root="77907b15-a68f-4435-a4bd-1e4b9b73c042"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>6.1	Clinical Trials Experience </title>
                     <text>
                        <paragraph>Because clinical trials are conducted under widely varying conditions, adverse reactions rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.</paragraph>
                        <paragraph>Most common treatment-emergent adverse reactions, occurring in greater than 2% of adult patients in both Intensive Care Unit and procedural sedation studies include hypotension, bradycardia and dry mouth.</paragraph>
                        <paragraph>
                           <content styleCode="underline">Intensive Care Unit Sedation</content>
                        </paragraph>
                        <paragraph>Adverse reaction information is derived from the continuous infusion trials of PRECEDEX for sedation in the Intensive Care Unit setting in which 1,007 adult patients received PRECEDEX. The mean total dose was 7.4 mcg/kg (range: 0.8 to 84.1), mean dose per hour was 0.5 mcg/kg/hr (range: 0.1 to 6.0) and the mean duration of infusion of 15.9 hours (range: 0.2 to 157.2). The population was between 17 to 88 years of age, 43% ≥65 years of age, 77% male and 93% Caucasian. Treatment-emergent adverse reactions occurring at an incidence of &gt;2% are provided in <linkHtml href="#_RefTable3">Table 3</linkHtml>. The most frequent adverse reactions were hypotension, bradycardia and dry mouth <content styleCode="italics">[see <linkHtml href="#ID_000c8ebe-99fe-4683-9f3b-7c5d6ce8c381">Warnings and Precautions (5.2)</linkHtml>]</content>.</paragraph>
                        <table ID="_RefTable3" width="97.8%">
                           <caption>Table 3: Adverse Reactions with an Incidence &gt;2%-Adult Intensive Care Unit Sedation Population &lt;24 hours<footnote ID="_Ref114750343">26 subjects in the all PRECEDEX group and 10 subjects in the randomized PRECEDEX group had exposure for greater than 24 hours.</footnote>
                           </caption>
                           <col width="28%"/>
                           <col width="18%"/>
                           <col width="18%"/>
                           <col width="18%"/>
                           <col width="17%"/>
                           <tbody>
                              <tr>
                                 <td styleCode="Rrule Botrule Toprule " valign="bottom">
                                    <paragraph>
                                       <content styleCode="bold">Adverse Event</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="bottom">
                                    <paragraph>
                                       <content styleCode="bold">All PRECEDEX</content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">(N = 1007)</content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">(%)</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="bottom">
                                    <paragraph>
                                       <content styleCode="bold">Randomized PRECEDEX</content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">(N = 798)</content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">(%)</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="bottom">
                                    <paragraph>
                                       <content styleCode="bold">Placebo</content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">(N = 400)</content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">(%)</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule Lrule Toprule " valign="bottom">
                                    <paragraph>
                                       <content styleCode="bold">Propofol</content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">(N = 188)</content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">(%)</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Hypotension</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>25%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>24%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>12%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>13%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Hypertension</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>12%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>13%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>19%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>4%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Nausea</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>9%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>9%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>9%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>11%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Bradycardia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>5%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>5%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>0</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Atrial Fibrillation</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>4%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>5%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>7%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Pyrexia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>4%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>4%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>4%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>4%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Dry Mouth</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>4%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Vomiting</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>5%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Hypovolemia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>5%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Atelectasis</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>6%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Pleural Effusion</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>6%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Agitation</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Tachycardia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>4%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Anemia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Hyperthermia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>0</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Chills</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Hyperglycemia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Hypoxia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Post-procedural Hemorrhage</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>4%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Pulmonary Edema</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Hypocalcemia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Acidosis</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Urine Output Decreased</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Sinus Tachycardia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Ventricular Tachycardia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>&lt;1%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>5%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Wheezing</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>&lt;1%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule Toprule " valign="top">
                                    <paragraph>Edema Peripheral</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>&lt;1%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>0</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule Lrule Toprule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>Adverse reaction information was also derived from the placebo-controlled, continuous infusion trials of PRECEDEX for sedation in the surgical intensive care unit setting in which 387 adult patients received PRECEDEX for less than 24 hours. The most frequently observed treatment-emergent adverse events included hypotension, hypertension, nausea, bradycardia, fever, vomiting, hypoxia, tachycardia and anemia (see <linkHtml href="#_RefTable4">Table 4</linkHtml>).</paragraph>
                        <table ID="_RefTable4" width="97.8%">
                           <caption>Table 4: Treatment-Emergent Adverse Events Occurring in &gt;1% of All Dexmedetomidine-Treated Adult Patients in the Randomized Placebo-Controlled Continuous Infusion &lt;24 Hours ICU Sedation Studies </caption>
                           <col width="33%"/>
                           <col width="34%"/>
                           <col width="33%"/>
                           <tbody>
                              <tr>
                                 <td styleCode="Rrule Botrule Toprule " valign="bottom">
                                    <paragraph>
                                       <content styleCode="bold">Adverse Event</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Randomized Dexmedetomidine</content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">(N = 387)</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Placebo</content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">(N = 379)</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Hypotension</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>28%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>13%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Hypertension</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>16%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>18%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Nausea</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>11%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>9%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Bradycardia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>7%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Fever</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>5%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>4%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Vomiting</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>4%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>6%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Atrial Fibrillation</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>4%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Hypoxia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>4%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>4%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Tachycardia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>5%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Hemorrhage</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>4%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Anemia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Dry Mouth</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Rigors</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Agitation </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Hyperpyrexia </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Pain</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Hyperglycemia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Acidosis</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Pleural Effusion</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Oliguria</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>&lt;1%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule Toprule " valign="top">
                                    <paragraph>Thirst</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule Lrule Toprule " valign="top">
                                    <paragraph>&lt;1%</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>In a controlled clinical trial, PRECEDEX was compared to midazolam for ICU sedation exceeding 24 hours duration in adult patients. Key treatment emergent adverse events occurring in dexmedetomidine or midazolam treated adult patients in the randomized active comparator continuous infusion long-term intensive care unit sedation study are provided in <linkHtml href="#_RefTable5">Table 5</linkHtml>. The number (%) of adult subjects who had a dose-related increase in treatment-emergent adverse events by maintenance adjusted dose rate range in the PRECEDEX group is provided in <linkHtml href="#_RefTable6">Table 6</linkHtml>.</paragraph>
                        <table ID="_RefTable5" width="99.02%">
                           <caption>Table 5: Key Treatment-Emergent Adverse Events Occurring in Dexmedetomidine- or Midazolam-Treated Adult Patients in the Randomized Active Comparator Continuous Infusion Long-Term Intensive Care Unit Sedation Study</caption>
                           <col width="42%"/>
                           <col width="29%"/>
                           <col width="29%"/>
                           <tbody>
                              <tr>
                                 <td styleCode="Rrule Botrule Toprule " valign="bottom">
                                    <paragraph>
                                       <content styleCode="bold">Adverse Event</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Dexmedetomidine</content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">(N = 244)</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Midazolam</content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">(N = 122)</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Hypotension<footnote ID="_Ref183551747">Hypotension was defined in absolute terms as Systolic blood pressure of &lt;80 mmHg or Diastolic blood pressure of &lt;50 mmHg or in relative terms as ≤30% lower than pre-study drug infusion value.</footnote>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>56%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>56%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Hypotension Requiring Intervention</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>28%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>27%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Bradycardia<footnote ID="_Ref183551355">Bradycardia was defined in absolute terms as &lt;40 bpm or in relative terms as ≤30% lower than pre-study drug infusion value.</footnote>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>42%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>19%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Bradycardia Requiring Intervention</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>5%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Systolic Hypertension<footnote ID="_Ref183551391">Hypertension was defined in absolute terms as Systolic blood pressure &gt;180 mmHg or Diastolic blood pressure of &gt;100 mmHg or in relative terms as ≥30% higher than pre-study drug infusion value.</footnote>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>28%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>42%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Tachycardia<footnote ID="_Ref183551476">Tachycardia was defined in absolute terms as &gt;120 bpm or in relative terms as ≥30% greater than pre-study drug infusion value.</footnote>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>25%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>44%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Tachycardia Requiring Intervention</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>10%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>10%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Diastolic Hypertension<footnoteRef IDREF="_Ref183551391"/>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>12%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>15%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Hypertension<footnoteRef IDREF="_Ref183551391"/>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>11%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>15%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Hypertension Requiring Intervention<footnote ID="_Ref183551728">Includes any type of hypertension</footnote>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>19%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>30%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Hypokalemia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>9%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>13%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Pyrexia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>7%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Agitation</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>7%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>6%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Hyperglycemia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>7%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Constipation</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>6%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>6%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Hypoglycemia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>5%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>6%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Respiratory Failure</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>5%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Renal Failure Acute</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Acute Respiratory Distress Syndrome</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Generalized Edema</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>6%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule Toprule " valign="top">
                                    <paragraph>Hypomagnesemia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule Lrule Toprule " valign="top">
                                    <paragraph>7%</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>The following adverse events occurred between 2 and 5% for PRECEDEX and Midazolam, respectively: renal failure acute (2.5%, 0.8%), acute respiratory distress syndrome (2.5%, 0.8%), and respiratory failure (4.5%, 3.3%).</paragraph>
                        <table ID="_RefTable6" width="97.8%">
                           <caption>Table 6: Number (%) of Adult Subjects Who Had a Dose-Related Increase in Treatment Emergent Adverse Events by Maintenance Adjusted Dose Rate Range in the PRECEDEX Group</caption>
                           <col width="44%"/>
                           <col width="21%"/>
                           <col width="19%"/>
                           <col width="16%"/>
                           <tbody>
                              <tr>
                                 <td align="center" colspan="4" styleCode="Botrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">PRECEDEX (mcg/kg/hr)</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="bottom">
                                    <paragraph>
                                       <content styleCode="bold">Adverse Event</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">≤0.7</content>
                                       <footnote ID="_Ref114750898">Average maintenance dose over the entire study drug administration.</footnote>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">(N = 95)</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">&gt;0.7 to ≤1.1</content>
                                       <footnoteRef IDREF="_Ref114750898"/>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">(N = 78)</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">&gt;1.1</content>
                                       <footnoteRef IDREF="_Ref114750898"/>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">(N = 71)</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Constipation</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>6%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>5%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="middle">
                                    <paragraph>14%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Agitation</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>5%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>8%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="middle">
                                    <paragraph>14%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Anxiety</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>5%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>5%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="middle">
                                    <paragraph>9%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Edema Peripheral</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>3%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>5%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="middle">
                                    <paragraph>7%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Atrial Fibrillation</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>4%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="middle">
                                    <paragraph>9%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Respiratory Failure</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>6%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="middle">
                                    <paragraph>10%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule Toprule " valign="top">
                                    <paragraph>Acute Respiratory Distress Syndrome</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="middle">
                                    <paragraph>1%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="middle">
                                    <paragraph>3%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule Lrule Toprule " valign="middle">
                                    <paragraph>9%</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>
                           <content styleCode="underline">Adult Procedural Sedation</content>
                        </paragraph>
                        <paragraph>Adverse reaction information is derived from the two trials for adult procedural sedation <content styleCode="italics">[see <linkHtml href="#ID_141e5ed6-497d-4a32-81d1-caccfe8ecb04">Clinical Studies (14.2)</linkHtml>]</content> in which 318 adult patients received PRECEDEX. The mean total dose was 1.6 mcg/kg (range: 0.5 to 6.7), mean dose per hour was 1.3 mcg/kg/hr (range: 0.3 to 6.1) and the mean duration of infusion of 1.5 hours (range: 0.1 to 6.2). The population was between 18 to 93 years of age, ASA I-IV, 30% ≥65 years of age, 52% male and 61% Caucasian.</paragraph>
                        <paragraph>Treatment-emergent adverse reactions occurring in adults at an incidence of &gt;2% are provided in <linkHtml href="#_RefTable7">Table 7</linkHtml>. The most frequent adverse reactions were hypotension, bradycardia, and dry mouth <content styleCode="italics">[see <linkHtml href="#ID_000c8ebe-99fe-4683-9f3b-7c5d6ce8c381">Warnings and Precautions (5.2)</linkHtml>]</content>. Pre-specified criteria for the vital signs to be reported as adverse reactions are footnoted below the table. The decrease in respiratory rate and hypoxia was similar between PRECEDEX and comparator groups in both studies.</paragraph>
                        <table ID="_RefTable7" width="98%">
                           <caption>Table 7: Adverse Reactions with an Incidence &gt;2%— Adult Procedural Sedation Population</caption>
                           <col width="37%"/>
                           <col width="29%"/>
                           <col width="34%"/>
                           <thead>
                              <tr>
                                 <th align="left" styleCode="Rrule Botrule Toprule " valign="bottom">
                                    <content styleCode="bold">Adverse Event</content>
                                 </th>
                                 <th align="center" styleCode="Rrule Botrule Lrule Toprule " valign="bottom">
                                    <content styleCode="bold">PRECEDEX</content>
                                    <br/>
                                    <content styleCode="bold">(N = 318)</content>
                                    <br/>
                                    <content styleCode="bold">(%)</content>
                                 </th>
                                 <th align="center" styleCode="Botrule Lrule Toprule " valign="bottom">
                                    <content styleCode="bold">Placebo</content>
                                    <br/>
                                    <content styleCode="bold">(N = 113)</content>
                                    <br/>
                                    <content styleCode="bold">(%)</content>
                                 </th>
                              </tr>
                           </thead>
                           <tbody>
                              <tr>
                                 <td styleCode="Rrule Toprule Botrule " valign="top">
                                    <paragraph>Hypotension<footnote ID="_Ref126601594">Hypotension was defined in absolute and relative terms as Systolic blood pressure of &lt;80 mmHg or ≤30% lower than pre-study drug infusion value, or Diastolic blood pressure of &lt;50 mmHg.</footnote>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>54%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>30%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Respiratory Depression<footnote ID="_Ref126601771">Respiratory depression was defined in absolute and relative terms as respiratory rate (RR) &lt;8 beats per minute or &gt;25% decrease from baseline.</footnote>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>37%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>32%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Bradycardia<footnote ID="_Ref126601784">Bradycardia was defined in absolute and relative terms as &lt;40 beats per minute or ≤30% lower than pre-study drug infusion value. Subjects in Study 2 were pretreated with glycopyrrolate 0.1 mg intravenously before receiving study drug <content styleCode="italics">[see <linkHtml href="#ID_141e5ed6-497d-4a32-81d1-caccfe8ecb04">Clinical Studies (14.2)</linkHtml>]</content>.</footnote>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>14%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>4%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Hypertension<footnote ID="_Ref126601818">Hypertension was defined in absolute and relative terms as Systolic blood pressure &gt;180 mmHg or ≥30% higher than pre-study drug infusion value or Diastolic blood pressure of &gt;100 mmHg.</footnote>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>13%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>24%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Tachycardia<footnote ID="_Ref126601829">Tachycardia was defined in absolute and relative terms as &gt;120 beats per minute or ≥30% greater than pre-study drug infusion value.</footnote>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>5%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>17%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Nausea</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Dry Mouth</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>1%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Hypoxia<footnote ID="_Ref126601849">Hypoxia was defined in absolute and relative terms as SpO<sub>2</sub> &lt;90% or 10% decrease from baseline.</footnote>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>3%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule Toprule " valign="top">
                                    <paragraph>Bradypnea</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>2%</paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule Lrule Toprule " valign="top">
                                    <paragraph>4%</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>
                           <content styleCode="underline">Pediatric Sedation for Magnetic Resonance Imaging</content>
                        </paragraph>
                        <paragraph>Adverse reaction information is derived from a trial for sedation of pediatric procedural during a non‑invasive procedure <content styleCode="italics">[see <linkHtml href="#ID_141e5ed6-497d-4a32-81d1-caccfe8ecb04">Clinical Studies (14.2)</linkHtml>]</content> in which 122 pediatric patients aged 1 month to less than 17 years undergoing magnetic resonance imaging (MRI) scans received PRECEDEX. In pediatric patients 1 month to less than 2 years old, the median total dose for the PRECEDEX low, middle, and high dose treatment groups was 8.30, 18.90, and 22.75 mcg, respectively. The median duration of treatment ranged from 52.5 to 69 minutes across treatment groups. In pediatric patients 2 to less than 17 years old, the median total dose for the PRECEDEX low, middle, and high dose treatment groups was 21.30, 43.90, and 80.25 mcg, respectively. The median duration of treatment ranged from 56.5 to 66 minutes across treatment groups. </paragraph>
                        <paragraph>All-causality treatment-emergent adverse reactions occurring in the combined age group of pediatric patients during the procedure at an incidence of &gt;5% are provided in <linkHtml href="#_RefTable8">Table 8</linkHtml>. The most frequent treatment-emergent adverse events were bradypnea, bradycardia, hypertension, and hypotension <content styleCode="italics">[see <linkHtml href="#ID_000c8ebe-99fe-4683-9f3b-7c5d6ce8c381">Warnings and Precautions (5.2,</linkHtml>
                              <linkHtml href="#ID_c65dc109-c8ac-4cf8-b3c0-838f08a62600"> 5.3</linkHtml>)]</content>. In the combined age group and in each age group, increased incidence in bradycardia and hypertension was observed with increasing PRECEDEX dose. Mild transient withdrawal symptoms of emergence delirium or agitation occurred in 3 of 122 patients after discontinuation of PRECEDEX infusion <content styleCode="italics">[see <linkHtml href="#ID_b047b720-2925-4e4e-b30c-b8e1f3879bfd">Warnings and Precautions (5.5)</linkHtml>]</content>. All reported treatment‑emergent adverse reactions were mild to moderate in severity and the majority resolved without medical intervention. No subject in the study required airway intervention, including a jaw thrust or insertion of a nasal or oral airway. A similar profile was observed in the pediatric patients 1 month to less than 2 years old and in pediatric patients 2 to less than 17 years old. Pre‑specified criteria for the vital signs to be reported as adverse events are footnoted below the table. </paragraph>
                        <table ID="_RefTable8" width="97.8%">
                           <caption>Table 8: Treatment-Emergent Adverse Events with Incidence &gt;5%—Pediatric Patients During Non-invasive Procedure</caption>
                           <col width="39%"/>
                           <col width="17%"/>
                           <col width="17%"/>
                           <col width="17%"/>
                           <col width="11%"/>
                           <tfoot>
                              <tr>
                                 <td align="left" colspan="5" valign="top">N = Number of pediatric patients evaluable for adverse events.</td>
                              </tr>
                           </tfoot>
                           <tbody>
                              <tr>
                                 <td styleCode="Rrule Botrule Lrule Toprule " valign="top"/>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">PRECEDEX</content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">Low Dose</content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">(N = 42)</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">PRECEDEX</content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">Middle Dose</content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">(N = 42)</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">PRECEDEX</content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">High Dose</content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">(N = 38)</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Total</content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">(N = 122)</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Number (%) of Pediatric Patients</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">n (%)</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">n (%)</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">n (%)</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">n (%)</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Adverse Event</content>
                                    </paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top"/>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Bradypnea<footnote ID="_Ref126601964">Bradypnea was defined as respiratory rate &lt;1<sup>st</sup> centile of the age adjusted normal range.</footnote>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>33 (79)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>27 (64)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>22 (58)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>82 (67)</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Bradycardia<footnote ID="_Ref126602075">Bradycardia was defined as a decrease in HR of 30% from baseline or absolute HR ≤1<sup>st</sup> centile of the age adjusted normal range.</footnote>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>24 (57)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>24 (57)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>27 (71)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>75 (62)</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Hypertension<footnote ID="_Ref126602095">For pediatric patients 1 month to less than 1 year old, hypertension was defined as supine systolic blood pressure ≥104 mm/Hg and/or diastolic blood pressure ≥56 mmHg measurements. For pediatric patients 1 to less than 17 years old: hypertension was defined as supine systolic blood pressure and/or diastolic blood pressure measurements ≥95<sup>th</sup> percentile for gender, age, and height.</footnote>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>11 (26)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>17 (41)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>18 (47)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>46 (38)</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Hypotension<footnote ID="_Ref126602113">Hypotension was defined as a decrease in systolic blood pressure ≥30% from baseline.</footnote>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>13 (31)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>11 (26)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>6 (16)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>30 (25)</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Hypoxia<footnote ID="_Ref183552000">Hypoxia was defined as oxygen saturation &lt;90% for any duration.</footnote>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>6 (14)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3 (7)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1 (3)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>10 (8)</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Diastolic Hypertension<footnoteRef IDREF="_Ref126602095"/>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3 (7)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3 (7)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>4 (11)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>10 (8)</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Systolic Hypertension<footnoteRef IDREF="_Ref126602095"/>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1 (2)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>5 (12)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3 (8)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>9 (7)</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>Tachycardia</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>3 (7)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>1 (2)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>1 (3)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>5 (4)</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                     </text>
                     <effectiveTime value="20221212"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_8b47bcb3-d522-442c-a915-f524537a9bc1">
                     <id root="831b5581-4d26-4db1-8449-4e2d9f20a1c9"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>6.2	Postmarketing Experience </title>
                     <text>
                        <paragraph>The following adverse reactions have been identified during post-approval use of PRECEDEX. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.</paragraph>
                        <paragraph>Hypotension and bradycardia were the most common adverse reactions associated with the use of PRECEDEX during post-approval use of the drug.</paragraph>
                        <table ID="_RefID0EFOAI" width="100%">
                           <caption>Table 9: Adverse Reactions Experienced During Post-Approval Use of PRECEDEX</caption>
                           <col width="38%"/>
                           <col width="62%"/>
                           <tbody>
                              <tr>
                                 <td styleCode="Rrule Botrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">System Organ Class</content>
                                    </paragraph>
                                 </td>
                                 <td styleCode="Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Preferred Term</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Blood and Lymphatic System Disorders</paragraph>
                                 </td>
                                 <td styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>Anemia</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Cardiac Disorders</paragraph>
                                 </td>
                                 <td styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>Arrhythmia, atrial fibrillation, atrioventricular block, bradycardia, cardiac arrest, cardiac disorder, extrasystoles, myocardial infarction, supraventricular tachycardia, tachycardia, ventricular arrhythmia, ventricular tachycardia</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Eye Disorders</paragraph>
                                 </td>
                                 <td styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>Photopsia, visual impairment</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Gastrointestinal Disorders</paragraph>
                                 </td>
                                 <td styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>Abdominal pain, diarrhea, nausea, vomiting</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>General Disorders and Administration Site Conditions</paragraph>
                                 </td>
                                 <td styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>Chills, hyperpyrexia, pain, pyrexia, thirst</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Hepatobiliary Disorders</paragraph>
                                 </td>
                                 <td styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>Hepatic function abnormal, hyperbilirubinemia</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Investigations</paragraph>
                                 </td>
                                 <td styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>Alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood urea increased, electrocardiogram T wave inversion, gammaglutamyltransferase increased, electrocardiogram QT prolonged</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Metabolism and Nutrition Disorders</paragraph>
                                 </td>
                                 <td styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>Acidosis, hyperkalemia, hypoglycemia, hypovolemia, hypernatremia</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Nervous System Disorders</paragraph>
                                 </td>
                                 <td styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>Convulsion, dizziness, headache, neuralgia, neuritis, speech disorder</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Psychiatric Disorders</paragraph>
                                 </td>
                                 <td styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>Agitation, confusional state, delirium, hallucination, illusion</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Renal and Urinary Disorders</paragraph>
                                 </td>
                                 <td styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>Oliguria, polyuria</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Respiratory, Thoracic and Mediastinal Disorders</paragraph>
                                 </td>
                                 <td styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>Apnea, bronchospasm, dyspnea, hypercapnia, hypoventilation, hypoxia, pulmonary congestion, respiratory acidosis</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Skin and Subcutaneous Tissue Disorders</paragraph>
                                 </td>
                                 <td styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>Hyperhidrosis, pruritus, rash, urticaria</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Surgical and Medical Procedures</paragraph>
                                 </td>
                                 <td styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>Light anesthesia</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule Toprule " valign="top">
                                    <paragraph>Vascular Disorders</paragraph>
                                 </td>
                                 <td styleCode="Botrule Lrule Toprule " valign="top">
                                    <paragraph>Blood pressure fluctuation, hemorrhage, hypertension, hypotension</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                     </text>
                     <effectiveTime value="20221212"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_DFC9FDB7-EF47-4E31-84FA-9C530709E947">
               <id root="d41810e0-1f06-457e-b7ca-9813b9a3c1f7"/>
               <code code="34073-7" codeSystem="2.16.840.1.113883.6.1" displayName="DRUG INTERACTIONS SECTION"/>
               <title>7 DRUG INTERACTIONS </title>
               <effectiveTime value="20221212"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>Anesthetics, Sedatives, Hypnotics, Opioids: Enhancement of pharmacodynamic effects. Reduction in dosage of PRECEDEX or the concomitant medication may be required. (<linkHtml href="#ID_254ee44e-44fd-4f86-9f26-b1c4773a3cf2">7.1</linkHtml>)</paragraph>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="ID_254ee44e-44fd-4f86-9f26-b1c4773a3cf2">
                     <id root="254ee44e-44fd-4f86-9f26-b1c4773a3cf2"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>7.1	Anesthetics, Sedatives, Hypnotics, Opioids </title>
                     <text>
                        <paragraph>Co-administration of PRECEDEX with anesthetics, sedatives, hypnotics, and opioids is likely to lead to an enhancement of effects. Specific studies have confirmed these effects with sevoflurane, isoflurane, propofol, alfentanil, and midazolam. No pharmacokinetic interactions between PRECEDEX and isoflurane, propofol, alfentanil and midazolam have been demonstrated. However, due to possible pharmacodynamic interactions, when co-administered with PRECEDEX, a reduction in dosage of PRECEDEX or the concomitant anesthetic, sedative, hypnotic or opioid may be required.</paragraph>
                     </text>
                     <effectiveTime value="20221214"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_eec8a5ed-4249-4822-b3c6-8eabfc900604">
                     <id root="eec8a5ed-4249-4822-b3c6-8eabfc900604"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>7.2	Neuromuscular Blockers </title>
                     <text>
                        <paragraph>In one study of 10 healthy adult volunteers, administration of PRECEDEX for 45 minutes at a plasma concentration of one ng/mL resulted in no clinically meaningful increases in the magnitude of neuromuscular blockade associated with rocuronium administration.</paragraph>
                     </text>
                     <effectiveTime value="20221214"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_609291B3-9B65-41B7-8889-4DB666816BCE">
               <id root="4c7b9586-e570-483e-bbc1-a4be4c432190"/>
               <code code="43684-0" codeSystem="2.16.840.1.113883.6.1" displayName="USE IN SPECIFIC POPULATIONS SECTION"/>
               <title>8 USE IN SPECIFIC POPULATIONS </title>
               <effectiveTime value="20221212"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered">
                           <item>
                              <caption>•</caption>Geriatric Patients: Dose reduction should be considered. (<linkHtml href="#ID_8be24d35-77bd-487e-83d0-7d04dd1ad70b">2.2</linkHtml>, <linkHtml href="#ID_419377a3-7a63-4deb-9e0e-9ed785cb3176">2.3</linkHtml>, <linkHtml href="#ID_000c8ebe-99fe-4683-9f3b-7c5d6ce8c381">5.2</linkHtml>, <linkHtml href="#ID_58E58B61-CA0C-4C22-9F96-DC0FFFD6E213">8.5</linkHtml>)</item>
                           <item>
                              <caption>•</caption>Hepatic Impairment: Dose reduction should be considered. (<linkHtml href="#ID_8be24d35-77bd-487e-83d0-7d04dd1ad70b">2.2</linkHtml>, <linkHtml href="#ID_419377a3-7a63-4deb-9e0e-9ed785cb3176">2.3</linkHtml>, <linkHtml href="#ID_24d08c94-822b-421c-8fba-aadac1eab6c9">5.8</linkHtml>, <linkHtml href="#ID_668886b6-74b7-4db8-8215-95af554384a5">8.6</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="ID_E154D95A-9E00-4176-B787-8FC344E272FA">
                     <id root="ea99f1ac-ad17-4d10-aadf-af4c774bc8e9"/>
                     <code code="42228-7" codeSystem="2.16.840.1.113883.6.1" displayName="PREGNANCY SECTION"/>
                     <title>8.1 Pregnancy </title>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Risk Summary</content>
                        </paragraph>
                        <paragraph>Available data from published randomized controlled trials and case reports over several decades of use with intravenously administered dexmedetomidine during pregnancy have not identified a drug-associated risk of major birth defects and miscarriage; however, the reported exposures occurred after the first trimester. Most of the available data are based on studies with exposures that occurred at the time of caesarean section delivery, and these studies have not identified an adverse effect on maternal outcomes or infant Apgar scores. Available data indicate that dexmedetomidine crosses the placenta. </paragraph>
                        <paragraph>In animal reproduction studies, fetal toxicity that lower fetal viability and reduced live fetuses occurred with subcutaneous administration of dexmedetomidine to pregnant rats during organogenesis at doses 1.8 times the maximum recommended human dose (MRHD) of 17.8 mcg/kg/day. </paragraph>
                        <paragraph>Developmental toxicity (low pup weights and adult offspring weights, decreased F1 grip strength, increased early implantation loss and decreased viability of second-generation offspring) occurred when pregnant rats were subcutaneously administered dexmedetomidine at doses less than the clinical dose from late pregnancy through lactation and weaning <content styleCode="italics">(see <linkHtml href="#_Refdata">Data</linkHtml>)</content>.</paragraph>
                        <paragraph>The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. All pregnancies have a background risk of birth defect, loss, or other adverse outcomes. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. </paragraph>
                        <paragraph>
                           <content styleCode="underline">Data</content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="italics">Animal Data </content>
                        </paragraph>
                        <paragraph>Increased post-implantation losses and reduced live fetuses in the presence of maternal toxicity (i.e. decreased body weight) were noted in a rat embryo-fetal development study in which pregnant dams were administered subcutaneous doses of dexmedetomidine 200 mcg/kg/day (equivalent to 1.8 times the intravenous MRHD of 17.8 mcg/kg/day based on body surface area [BSA]) during the period of organogenesis (Gestation Day [GD] 6 to 15). No malformations were reported.</paragraph>
                        <paragraph>No malformations or embryo-fetal toxicity were noted in a rabbit embryo-fetal development study in which pregnant does were administered dexmedetomidine intravenously at doses of up to 96 mcg/kg/day (approximately half the human exposure at the MRHD based on AUC) during the period of organogenesis (GD 6 to 18).</paragraph>
                        <paragraph>Reduced pup and adult offspring birth weights, and grip strength were reported in a rat developmental toxicology study in which pregnant females were administered dexmedetomidine subcutaneously at doses of 8 mcg/kg/day (0.07 times the MRHD based on BSA) during late pregnancy through lactation and weaning (GD 16 to postnatal day [PND] 25). Decreased viability of second generation offspring and an increase in early implantation loss along with delayed motor development occurred in the 32 mcg/kg/day group (equivalent to less than the clinical dose based on BSA) when first generation offspring were allowed to mate. This study limited dosing to hard palate closure (GD 15 to 18) through weaning instead of dosing from implantation (GD 6 to 7) to weaning (PND 21). </paragraph>
                        <paragraph>In a study in the pregnant rat, placental transfer of dexmedetomidine was observed when radiolabeled dexmedetomidine was administered subcutaneously.</paragraph>
                     </text>
                     <effectiveTime value="20221212"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_5D9FB002-5996-4EC7-BECC-89F13C00E58E">
                     <id root="dce4b489-ea0c-4223-ad50-1c10db010f2c"/>
                     <code code="77290-5" codeSystem="2.16.840.1.113883.6.1" displayName="LACTATION SECTION"/>
                     <title>8.2 Lactation </title>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Risk Summary</content>
                        </paragraph>
                        <paragraph>Available published literature reports the presence of dexmedetomidine in human milk following intravenous administration <content styleCode="italics">(see <linkHtml href="#_RefD">Data</linkHtml>)</content>. There is no information regarding the effects of dexmedetomidine on the breastfed infant or the effects on milk production. Advise women to monitor the breastfed infant for irritability. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for PRECEDEX and any potential adverse effects on the breastfed infant from PRECEDEX or from the underlying condition.</paragraph>
                        <paragraph>
                           <content styleCode="underline">Data</content>
                        </paragraph>
                        <paragraph>In two published clinical studies, a total of 14 women were given intravenous dexmedetomidine 6 mcg/kg/hour for 10 minutes after delivery followed by continuous infusion of 0.2–0.7 mcg/kg/hour. Breast milk and maternal blood samples were collected at 0, 6, 12, and 24 hours after discontinuation of dexmedetomidine. Plasma and milk dexmedetomidine concentrations were detectable up to 6 hours in most subjects, up to 12 hours in one subject and undetectable in all at 24 hours. The milk-to-plasma ratio from single paired maternal milk and plasma concentrations at each time point ranged from 0.53 to 0.95. The relative infant dose was estimated to range from 0.02 to 0.098%.</paragraph>
                     </text>
                     <effectiveTime value="20221212"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_92D019A0-649B-414D-82EA-D663E27A62E2">
                     <id root="bb6dfb48-4551-4f7a-8540-3b2ece789b46"/>
                     <code code="34081-0" codeSystem="2.16.840.1.113883.6.1" displayName="PEDIATRIC USE SECTION"/>
                     <title>8.4 Pediatric Use </title>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Sedation for Non-Invasive Procedures</content>
                        </paragraph>
                        <paragraph>The safety and efficacy of PRECEDEX have been established in pediatric patients 1 month to less than 18 years of age for sedation during non-invasive procedures. Use in this age group is based on one randomized double-blind, dose-ranging safety and efficacy trial in non-intubated pediatric patients 1 month to less than 17 years of age who required sedation prior to undergoing MRI scans <content styleCode="italics">[see <linkHtml href="#ID_141e5ed6-497d-4a32-81d1-caccfe8ecb04">Clinical Studies (14.2)</linkHtml>]</content>. An increase in frequency of bradypnea, bradycardia, hypertension and hypotension was observed in pediatric patients treated with PRECEDEX <content styleCode="italics">[see <linkHtml href="#ID_b91b0be6-1ca3-468d-a2fe-c3f1e6176758">Adverse Reactions (6.1)</linkHtml>]. </content>The overall safety profile of PRECEDEX in pediatric patients was consistent with the known safety profile in adults<content styleCode="italics"> [see <linkHtml href="#ID_b91b0be6-1ca3-468d-a2fe-c3f1e6176758">Adverse Reactions (6.1)</linkHtml>]</content>.</paragraph>
                        <paragraph>The safety and effectiveness of PRECEDEX have not been established in pediatric patients less than 1 month of age.</paragraph>
                        <paragraph>
                           <content styleCode="underline">ICU Sedation</content>
                        </paragraph>
                        <paragraph>The safety and efficacy of PRECEDEX have not been established in pediatric patients for ICU sedation. One assessor-blinded trial in pediatric patients and two open label studies in neonates were conducted to assess efficacy for ICU sedation. These studies did not meet their primary efficacy endpoints and the safety data submitted were insufficient to fully characterize the safety profile of PRECEDEX for these patient populations.</paragraph>
                     </text>
                     <effectiveTime value="20221201"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_58E58B61-CA0C-4C22-9F96-DC0FFFD6E213">
                     <id root="28cebd60-5d99-4280-be9c-58ecd5c61d7c"/>
                     <code code="34082-8" codeSystem="2.16.840.1.113883.6.1" displayName="GERIATRIC USE SECTION"/>
                     <title>8.5 Geriatric Use </title>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Intensive Care Unit Sedation</content>
                        </paragraph>
                        <paragraph>A total of 729 patients in the clinical studies were 65 years of age and over. A total of 200 patients were 75 years of age and over. In patients greater than 65 years of age, a higher incidence of bradycardia and hypotension was observed following administration of PRECEDEX <content styleCode="italics">[see <linkHtml href="#ID_000c8ebe-99fe-4683-9f3b-7c5d6ce8c381">Warnings and Precautions (5.2)</linkHtml>]</content>. Therefore, a dose reduction may be considered in patients over 65 years of age <content styleCode="italics">[see <linkHtml href="#ID_8be24d35-77bd-487e-83d0-7d04dd1ad70b">Dosage and Administration (2.2</linkHtml>, <linkHtml href="#ID_419377a3-7a63-4deb-9e0e-9ed785cb3176">2.3</linkHtml>), <linkHtml href="#ID_5427497F-654A-4F81-B0AB-2756258A55DE">Clinical Pharmacology (12.3)</linkHtml>]</content>.</paragraph>
                        <paragraph>
                           <content styleCode="underline">Procedural Sedation</content>
                        </paragraph>
                        <paragraph>A total of 131 patients in the clinical studies were 65 years of age and over. A total of 47 patients were 75 years of age and over. Hypotension occurred in a higher incidence in PRECEDEX-treated patients 65 years or older (72%) and 75 years or older (74%) as compared to patients &lt;65 years (47%). A reduced loading dose of 0.5 mcg/kg given over 10 minutes is recommended and a reduction in the maintenance infusion should be considered for patients greater than 65 years of age.</paragraph>
                     </text>
                     <effectiveTime value="20221201"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_668886b6-74b7-4db8-8215-95af554384a5">
                     <id root="64862432-b296-4a8c-8ac7-bf3cf91f5966"/>
                     <code code="88829-7" codeSystem="2.16.840.1.113883.6.1" displayName="HEPATIC IMPAIRMENT SUBSECTION"/>
                     <title>8.6 Hepatic Impairment </title>
                     <text>
                        <paragraph>Since PRECEDEX clearance decreases with increasing severity of hepatic impairment, dose reduction should be considered in patients with impaired hepatic function <content styleCode="italics">[see <linkHtml href="#ID_8be24d35-77bd-487e-83d0-7d04dd1ad70b">Dosage and Administration (2.2</linkHtml>, <linkHtml href="#ID_419377a3-7a63-4deb-9e0e-9ed785cb3176">2.3)</linkHtml>, <linkHtml href="#ID_5427497F-654A-4F81-B0AB-2756258A55DE">Clinical Pharmacology (12.3)</linkHtml>]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20221212"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_4FC5E033-20F0-4B21-9F66-0FDEBB2AD464">
               <id root="3e965531-6a38-485a-99dc-2e3716cedb12"/>
               <code code="42227-9" codeSystem="2.16.840.1.113883.6.1" displayName="DRUG ABUSE AND DEPENDENCE SECTION"/>
               <title>9 DRUG ABUSE AND DEPENDENCE</title>
               <effectiveTime value="20221201"/>
               <component>
                  <section ID="ID_08815CD2-41D7-45FA-B25E-D2EEF6F8E4F9">
                     <id root="2c757c72-f1df-4e6e-80f4-301e70beef83"/>
                     <code code="34085-1" codeSystem="2.16.840.1.113883.6.1" displayName="CONTROLLED SUBSTANCE SECTION"/>
                     <title>9.1 Controlled Substance </title>
                     <text>
                        <paragraph>PRECEDEX (dexmedetomidine hydrochloride) is not a controlled substance.</paragraph>
                     </text>
                     <effectiveTime value="20221214"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_1B261CDB-BC1A-4ECC-A8B6-DE8248317321">
                     <id root="81f4c2d2-ea60-4cb0-9327-440f6169ecd2"/>
                     <code code="34087-7" codeSystem="2.16.840.1.113883.6.1" displayName="DEPENDENCE SECTION"/>
                     <title>9.3 Dependence </title>
                     <text>
                        <paragraph>The dependence potential of PRECEDEX has not been studied in humans. However, since studies in rodents and primates have demonstrated that PRECEDEX exhibits pharmacologic actions similar to those of clonidine, it is possible that PRECEDEX may produce a clonidine-like withdrawal syndrome upon abrupt discontinuation <content styleCode="italics">[see <linkHtml href="#ID_b047b720-2925-4e4e-b30c-b8e1f3879bfd">Warnings and Precautions (5.5)</linkHtml>]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20221201"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_687CA54B-1B83-4121-A351-535EEA9B04C5">
               <id root="5ca5aa78-40c6-4529-a115-39c961c2d581"/>
               <code code="34088-5" codeSystem="2.16.840.1.113883.6.1" displayName="OVERDOSAGE SECTION"/>
               <title>10 OVERDOSAGE </title>
               <text>
                  <paragraph>The tolerability of PRECEDEX was studied in one study in which healthy adult subjects were administered doses at and above the recommended dose of 0.2 to 0.7 mcg/kg/hr. The maximum blood concentration achieved in this study was approximately 13 times the upper boundary of the therapeutic range. The most notable effects observed in two subjects who achieved the highest doses were first degree atrioventricular block and second‑degree heart block. No hemodynamic compromise was noted with the atrioventricular block and the heart block resolved spontaneously within one minute.</paragraph>
                  <paragraph>Five adult patients received an overdose of PRECEDEX in the intensive care unit sedation studies. Two of these patients had no symptoms reported; one patient received a 2 mcg/kg loading dose over 10 minutes (twice the recommended loading dose) and one patient received a maintenance infusion of 0.8 mcg/kg/hr. Two other patients who received a 2 mcg/kg loading dose over 10 minutes, experienced bradycardia and/or hypotension. One patient who received a loading bolus dose of undiluted PRECEDEX (19.4 mcg/kg), had cardiac arrest from which he was successfully resuscitated.</paragraph>
               </text>
               <effectiveTime value="20221212"/>
            </section>
         </component>
         <component>
            <section ID="ID_456D9BB1-9399-4942-AA62-E65CB074D378">
               <id root="cdcd4fac-1017-434d-b0cd-c43e68ffe017"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title>11 DESCRIPTION </title>
               <text>
                  <paragraph>PRECEDEX (dexmedetomidine hydrochloride) in 0.9% Sodium Chloride Injection (4 mcg/mL) is a sterile, nonpyrogenic ready to use solution suitable for intravenous infusion. </paragraph>
                  <paragraph>PRECEDEX contains dexmedetomidine hydrochloride as the active pharmaceutical ingredient. Dexmedetomidine hydrochloride is a central alpha<sub>2</sub>-adrenergic agonist. Dexmedetomidine hydrochloride is the S-enantiomer of medetomidine. Dexmedetomidine hydrochloride chemical name is 1H-Imidazole, 4-[1-(2,3-dimethylphenyl)ethyl, monohydrochloride, (S). Dexmedetomidine hydrochloride has a molecular weight of 236.7 and the empirical formula is C<sub>13</sub>H<sub>16</sub>N<sub>2</sub> • HCl and the structural formula is:</paragraph>
                  <renderMultiMedia ID="id793485911" referencedObject="ID_0c0901a8-d9fe-4447-ba8e-da203726d065"/>
                  <paragraph>PRECEDEX in 0.9% Sodium Chloride Injection is ready to be used. It is supplied as a clear, colorless, isotonic solution with a pH between 4.5 to 8.0. Each mL contains 4.72 mcg of dexmedetomidine hydrochloride (equivalent to 4 mcg or 0.004 mg of dexmedetomidine) and 9 mg sodium chloride in water for injection. The solution is preservative-free and contains no additives or chemical stabilizers.</paragraph>
               </text>
               <effectiveTime value="20221214"/>
               <component>
                  <observationMedia ID="ID_0c0901a8-d9fe-4447-ba8e-da203726d065">
                     <text>Chemical structure</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="precedex-01.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_22A22906-56CC-4CC4-8B09-930C99F00F92">
               <id root="ecbbb327-f88f-41aa-aeec-604f2651eab6"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>12 CLINICAL PHARMACOLOGY</title>
               <effectiveTime value="20221212"/>
               <component>
                  <section ID="ID_95166764-D077-4231-BB10-9FE1CA39F919">
                     <id root="0431142e-4cfe-42fb-9180-a2d13afbb0f6"/>
                     <code code="43679-0" codeSystem="2.16.840.1.113883.6.1" displayName="MECHANISM OF ACTION SECTION"/>
                     <title>12.1 Mechanism of Action </title>
                     <text>
                        <paragraph>PRECEDEX is a relatively selective centrally acting alpha<sub>2</sub>-adrenergic agonist with sedative properties. Alpha<sub>2</sub> selectivity is observed in animals following slow intravenous infusion of low and medium doses (10-300 mcg/kg). Both alpha<sub>1</sub> and alpha<sub>2</sub> activity is observed following slow intravenous infusion of high doses (≥1,000 mcg/kg) or with rapid intravenous administration.</paragraph>
                     </text>
                     <effectiveTime value="20221214"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_A04B7E69-7EE0-41E3-B633-B714554404DD">
                     <id root="29580340-83a1-4b6d-89e4-2b6e60b8176a"/>
                     <code code="43681-6" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACODYNAMICS SECTION"/>
                     <title>12.2 Pharmacodynamics </title>
                     <text>
                        <paragraph>In a study in healthy adult volunteers (N = 10), respiratory rate and oxygen saturation remained within normal limits and there was no evidence of respiratory depression when PRECEDEX was administered by intravenous infusion at doses within the recommended dose range (0.2–0.7 mcg/kg/hr).</paragraph>
                     </text>
                     <effectiveTime value="20221212"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_5427497F-654A-4F81-B0AB-2756258A55DE">
                     <id root="42844a6d-2e13-4827-9c36-79c981041c5a"/>
                     <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                     <title>12.3 Pharmacokinetics </title>
                     <text>
                        <paragraph>Following intravenous administration to adults, dexmedetomidine exhibits the following pharmacokinetic parameters: a rapid distribution phase with a distribution half-life (t<sub>1/2</sub>) of approximately 6 minutes; a terminal elimination half-life (t<sub>1/2</sub>) of approximately 2 hours; and steady-state volume of distribution (V<sub>ss</sub>) of approximately 118 liters. Clearance is estimated to be approximately 39 L/h. The mean body weight associated with this clearance estimate was 72 kg.</paragraph>
                        <paragraph>Dexmedetomidine exhibits linear pharmacokinetics in the dosage range of 0.2 to 0.7 mcg/kg/hr when administered to adults by intravenous infusion for up to 24 hours. <linkHtml href="#_RefTable10">Table 10</linkHtml> shows the main pharmacokinetic parameters when PRECEDEX was infused (after appropriate loading doses) at maintenance infusion rates of 0.17 mcg/kg/hr (target plasma concentration of 0.3 ng/mL) for 12 and 24 hours, 0.33 mcg/kg/hr (target plasma concentration of 0.6 ng/mL) for 24 hours, and 0.70 mcg/kg/hr (target plasma concentration of 1.25 ng/mL) for 24 hours.</paragraph>
                        <table ID="_RefTable10" width="97.8%">
                           <caption>Table 10: Mean ± SD Pharmacokinetic Parameters in Adults</caption>
                           <col width="20%"/>
                           <col width="21%"/>
                           <col width="20%"/>
                           <col width="19%"/>
                           <col width="19%"/>
                           <tfoot>
                              <tr>
                                 <td align="left" colspan="5" valign="top">Abbreviations: t<sub>1/2</sub> = half-life, CL = clearance, V<sub>ss</sub> = steady-state volume of distribution.</td>
                              </tr>
                           </tfoot>
                           <tbody>
                              <tr>
                                 <td rowspan="4" styleCode="Rrule Botrule Toprule " valign="bottom">
                                    <paragraph>
                                       <content styleCode="bold">Parameter</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" colspan="4" styleCode="Botrule Lrule Toprule " valign="middle">
                                    <paragraph>
                                       <content styleCode="bold">Loading Infusion (min)/Total Infusion Duration (hrs)</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>
                                       <content styleCode="bold">10 min/12 hrs</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>
                                       <content styleCode="bold">10 min/24 hrs</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>
                                       <content styleCode="bold">10 min/24 hrs</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="middle">
                                    <paragraph>
                                       <content styleCode="bold">35 min/24 hrs</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" colspan="4" styleCode="Lrule Toprule Botrule " valign="middle">
                                    <paragraph>
                                       <content styleCode="bold">Dexmedetomidine Target Plasma Concentration (ng/mL) and Dose (mcg/kg/hr)</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>
                                       <content styleCode="bold">0.3/0.17</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>
                                       <content styleCode="bold">0.3/0.17</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>
                                       <content styleCode="bold">0.6/0.33</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="middle">
                                    <paragraph>
                                       <content styleCode="bold">1.25/0.70</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="bottom">
                                    <paragraph>
                                       <content styleCode="bold">t<sub>1/2</sub>
                                       </content>
                                       <footnote ID="_Ref114752686">Presented as harmonic mean and pseudo standard deviation.</footnote>
                                       <content styleCode="bold">, hour</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>1.78 ± 0.30</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>2.22 ± 0.59</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>2.23 ± 0.21</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="middle">
                                    <paragraph>2.50 ± 0.61</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="bottom">
                                    <paragraph>
                                       <content styleCode="bold">CL, liter/hour</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>46.3 ± 8.3</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>43.1 ± 6.5</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>35.3 ± 6.8</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="middle">
                                    <paragraph>36.5 ± 7.5</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="bottom">
                                    <paragraph>
                                       <content styleCode="bold">V<sub>ss</sub>, liter </content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>88.7 ± 22.9</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>102.4 ± 20.3</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>93.6 ± 17.0</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="middle">
                                    <paragraph>99.6 ± 17.8</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule Toprule " valign="bottom">
                                    <paragraph>
                                       <content styleCode="bold">Avg C<sub>ss</sub>
                                       </content>
                                       <footnote ID="_Ref114752712">Mean C<sub>ss</sub> = Average steady-state concentration of dexmedetomidine. The mean C<sub>ss</sub> was calculated based on post-dose sampling from 2.5 to 9 hours samples for 12 hour infusion and post-dose sampling from 2.5 to 18 hours for 24 hour infusions.</footnote>
                                       <content styleCode="bold">, ng/mL</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="middle">
                                    <paragraph>0.27 ± 0.05</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="middle">
                                    <paragraph>0.27 ± 0.05</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="middle">
                                    <paragraph>0.67 ± 0.10</paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule Lrule Toprule " valign="middle">
                                    <paragraph>1.37 ± 0.20</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>The loading doses for each of the above indicated groups were 0.5, 0.5, 1 and 2.2 mcg/kg, respectively.</paragraph>
                        <paragraph>Dexmedetomidine pharmacokinetic parameters in adults after PRECEDEX maintenance doses of 0.2 to 1.4 mcg/kg/hr for &gt;24 hours were similar to the pharmacokinetic (PK) parameters after PRECEDEX maintenance dosing for &lt;24 hours in other studies. The values for clearance (CL), volume of distribution (V), and t<sub>1/2</sub> were 39.4 L/hr, 152 L, and 2.67 hours, respectively.</paragraph>
                        <paragraph>
                           <content styleCode="underline">Distribution</content>
                        </paragraph>
                        <paragraph>The steady-state volume of distribution (V<sub>ss</sub>) of dexmedetomidine was approximately 118 liters. Dexmedetomidine protein binding was assessed in the plasma of normal healthy male and female subjects. The average protein binding was 94% and was constant across the different plasma concentrations tested. Protein binding was similar in males and females. The fraction of PRECEDEX that was bound to plasma proteins was significantly decreased in subjects with hepatic impairment compared to healthy subjects.</paragraph>
                        <paragraph>The potential for protein binding displacement of dexmedetomidine by fentanyl, ketorolac, theophylline, digoxin and lidocaine was explored <content styleCode="italics">in vitro</content>, and negligible changes in the plasma protein binding of PRECEDEX were observed. The potential for protein binding displacement of phenytoin, warfarin, ibuprofen, propranolol, theophylline and digoxin by PRECEDEX was explored <content styleCode="italics">in vitro</content> and none of these compounds appeared to be significantly displaced by PRECEDEX.</paragraph>
                        <paragraph>
                           <content styleCode="underline">Elimination</content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="italics">Metabolism</content>
                        </paragraph>
                        <paragraph>Dexmedetomidine undergoes almost complete biotransformation with very little unchanged dexmedetomidine excreted in urine and feces. Biotransformation involves both direct glucuronidation as well as cytochrome P450 mediated metabolism. The major metabolic pathways of dexmedetomidine are: direct N-glucuronidation to inactive metabolites; aliphatic hydroxylation (mediated primarily by CYP2A6 with a minor role of CYP1A2, CYP2E1, CYP2D6 and CYP2C19) of dexmedetomidine to generate 3-hydroxy-dexmedetomidine, the glucuronide of 3-hydroxy-dexmedetomidine, and 3-carboxy-dexmedetomidine; and N-methylation of dexmedetomidine to generate 3-hydroxy N-methyl-dexmedetomidine, 3-carboxy N-methyl-dexmedetomidine, and dexmedetomidine-N-methyl O-glucuronide.</paragraph>
                        <paragraph>
                           <content styleCode="italics">Excretion</content>
                        </paragraph>
                        <paragraph>The terminal elimination half-life (t<sub>1/2</sub>) of dexmedetomidine is approximately 2 hours and clearance is estimated to be approximately 39 L/h. A mass balance study demonstrated that after nine days an average of 95% of the radioactivity, following intravenous administration of radiolabeled dexmedetomidine, was recovered in the urine and 4% in the feces. No unchanged dexmedetomidine was detected in the urine. Approximately 85% of the radioactivity recovered in the urine was excreted within 24 hours after the infusion. Fractionation of the radioactivity excreted in urine demonstrated that products of N-glucuronidation accounted for approximately 34% of the cumulative urinary excretion. In addition, aliphatic hydroxylation of parent drug to form 3-hydroxy-dexmedetomidine, the glucuronide of 3-hydroxy-dexmedetomidine, and 3-carboxylic acid-dexmedetomidine together represented approximately 14% of the dose in urine. N-methylation of dexmedetomidine to form 3-hydroxy N-methyl dexmedetomidine, 3-carboxy N-methyl dexmedetomidine, and N-methyl O-glucuronide dexmedetomidine accounted for approximately 18% of the dose in urine. The N-Methyl metabolite itself was a minor circulating component and was undetected in urine. Approximately 28% of the urinary metabolites have not been identified.</paragraph>
                        <paragraph>
                           <content styleCode="underline">Specific Populations</content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="italics">Male and Female Patients</content>
                        </paragraph>
                        <paragraph>There was no observed difference in PRECEDEX pharmacokinetics due to sex.</paragraph>
                        <paragraph>
                           <content styleCode="italics">Geriatric Patients</content>
                        </paragraph>
                        <paragraph>The pharmacokinetic profile of PRECEDEX was not altered by age. There were no differences in the pharmacokinetics of PRECEDEX in young (18–40 years), middle age (41–65 years), and elderly (&gt;65 years) subjects.</paragraph>
                        <paragraph>
                           <content styleCode="italics">Pediatric Patients</content>
                        </paragraph>
                        <paragraph>A population PK analysis was conducted with data collected from mechanically ventilated pediatric patients less than 17 years of age from 4 clinical studies. A linear 2-compartment model was found to best characterize the pooled dexmedetomidine concentration data. Mean PK parameters for each age group are summarized in <linkHtml href="#_RefTable11">Table 11</linkHtml>.</paragraph>
                        <table ID="_RefTable11" width="99.02%">
                           <caption>Table 11: Geometric Mean Point Estimates and 95% Confidence Intervals of PK Parameters by Pediatric Age Group</caption>
                           <col width="26%"/>
                           <col width="23%"/>
                           <col width="25%"/>
                           <col width="25%"/>
                           <tfoot>
                              <tr>
                                 <td align="left" colspan="4" valign="top">Abbreviations: CL = plasma clearance, Vc = volume of the central compartment.</td>
                              </tr>
                           </tfoot>
                           <tbody>
                              <tr>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Age Group</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">N</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">CL (L/h)</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Vc (L)</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>1 to less than 6 months</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>14</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>6.94 (5.46, 8.81)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>4.34 (3.25, 5.81)</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>6 to less than 12 months</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>15</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>8.15 (7.01, 9.47)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>7.29 (5.57, 9.53)</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>12 to less than 24 months</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>13</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>10.76 (9.09, 12.74)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>7.35 (5.59, 9.67)</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>2 to less than 6 years</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>26</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>15.89 (14.00, 18.04)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>13.78 (10.66, 17.83)</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>6 to less than 17 years</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>28</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>24.45 (19.34, 30.92)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>24.47 (17.06, 35.10)</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>
                           <content styleCode="italics">Patients with Hepatic Impairment</content>
                        </paragraph>
                        <paragraph>In adult subjects with varying degrees of hepatic impairment (Child-Pugh Class A, B, or C), clearance values for PRECEDEX were lower than in healthy subjects. The mean clearance values for patients with mild, moderate, and severe hepatic impairment were 74%, 64% and 53% of those observed in the normal healthy adult subjects, respectively. Mean clearances for free drug were 59%, 51% and 32% of those observed in the normal healthy adult subjects, respectively.</paragraph>
                        <paragraph>Although PRECEDEX is dosed to effect, it may be necessary to consider dose reduction in subjects with hepatic impairment <content styleCode="italics">[see <linkHtml href="#ID_8be24d35-77bd-487e-83d0-7d04dd1ad70b">Dosage and Administration (2.2)</linkHtml>, <linkHtml href="#ID_24d08c94-822b-421c-8fba-aadac1eab6c9">Warnings and Precautions (5.8)</linkHtml>]</content>.</paragraph>
                        <paragraph>
                           <content styleCode="italics">Patients with Renal Impairment</content>
                        </paragraph>
                        <paragraph>Dexmedetomidine pharmacokinetics (C<sub>max</sub>, T<sub>max</sub>, AUC, t<sub>1/2</sub>, CL, and V<sub>ss</sub>) were not significantly different in patients with severe renal impairment (creatinine clearance: &lt;30 mL/min) compared to healthy subjects.</paragraph>
                        <paragraph>
                           <content styleCode="underline">Drug Interaction Studies</content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="italics">In vitro</content> studies: <content styleCode="italics">In vitro</content> studies in human liver microsomes demonstrated no evidence of cytochrome P450 mediated drug interactions that are likely to be of clinical relevance.</paragraph>
                     </text>
                     <effectiveTime value="20221212"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_028186B9-1C32-46E9-990A-B2DCC40D3028">
               <id root="64fad293-edf7-418f-ad75-24ebfa8e8dc4"/>
               <code code="43680-8" codeSystem="2.16.840.1.113883.6.1" displayName="NONCLINICAL TOXICOLOGY SECTION"/>
               <title>13 NONCLINICAL TOXICOLOGY</title>
               <effectiveTime value="20221212"/>
               <component>
                  <section ID="ID_FE8615AB-908A-4E24-A8ED-9981C3D3EF5D">
                     <id root="70813019-39bf-40d0-bccb-d992bdd83298"/>
                     <code code="34083-6" codeSystem="2.16.840.1.113883.6.1" displayName="CARCINOGENESIS &amp; MUTAGENESIS &amp; IMPAIRMENT OF FERTILITY SECTION"/>
                     <title>13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility </title>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Carcinogenesis</content>
                        </paragraph>
                        <paragraph>Animal carcinogenicity studies have not been performed with dexmedetomidine.</paragraph>
                        <paragraph>
                           <content styleCode="underline">Mutagenesis</content>
                        </paragraph>
                        <paragraph>Dexmedetomidine was not mutagenic <content styleCode="italics">in vitro</content>, in either the bacterial reverse mutation assay (<content styleCode="italics">E. coli</content> and <content styleCode="italics">Salmonella typhimurium</content>) or the mammalian cell forward mutation assay (mouse lymphoma). Dexmedetomidine was clastogenic in the <content styleCode="italics">in vitro</content> human lymphocyte chromosome aberration test with, but not without, rat S9 metabolic activation. In contrast, dexmedetomidine was not clastogenic in the <content styleCode="italics">in vitro</content> human lymphocyte chromosome aberration test with or without human S9 metabolic activation. Although dexmedetomidine was clastogenic in an <content styleCode="italics">in vivo</content> mouse micronucleus test in NMRI mice, there was no evidence of clastogenicity in CD-1 mice.</paragraph>
                        <paragraph>
                           <content styleCode="underline">Impairment of Fertility</content>
                        </paragraph>
                        <paragraph>Fertility in male or female rats was not affected after daily subcutaneous injections of dexmedetomidine at doses up to 54 mcg/kg (less than the maximum recommended human intravenous dose on a mcg/m<sup>2</sup> basis) administered from 10 weeks prior to mating in males, and 3 weeks prior to mating and during mating in females.</paragraph>
                     </text>
                     <effectiveTime value="20221214"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_3074B59F-F873-4223-8127-5AC1F3A65383">
                     <id root="0bdffdd8-4b73-43c2-bd57-ef6edcc594c6"/>
                     <code code="34091-9" codeSystem="2.16.840.1.113883.6.1" displayName="ANIMAL PHARMACOLOGY &amp; OR TOXICOLOGY SECTION"/>
                     <title>13.2 Animal Toxicology and/or Pharmacology </title>
                     <text>
                        <paragraph>There were no differences in the adrenocorticotropic hormone (ACTH)-stimulated cortisol response in dogs following a single dose of dexmedetomidine compared to saline control. However, after continuous subcutaneous infusions of dexmedetomidine at 3 mcg/kg/hr and 10 mcg/kg/hr for one week in dogs (exposures estimated to be within the clinical range), the ACTH-stimulated cortisol response was diminished by approximately 27% and 40%, respectively, compared to saline-treated control animals indicating a dose-dependent adrenal suppression.</paragraph>
                     </text>
                     <effectiveTime value="20221214"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_30C43EDE-84A4-4E6D-B1A4-90D82F96B4B4">
               <id root="66df7203-884d-4096-8fb4-19877d8e2cf2"/>
               <code code="34092-7" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL STUDIES SECTION"/>
               <title>14 CLINICAL STUDIES </title>
               <text>
                  <paragraph>The safety and efficacy of PRECEDEX has been evaluated in four randomized, double-blind, placebo-controlled multicenter clinical trials in 1,185 adult patients.</paragraph>
               </text>
               <effectiveTime value="20221212"/>
               <component>
                  <section ID="ID_85b08884-e736-4b29-b7fe-f7fdbcc91a7c">
                     <id root="9d5f985b-06f2-4386-8014-c5e35472d6d8"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>14.1	Intensive Care Unit Sedation </title>
                     <text>
                        <paragraph>Two randomized, double-blind, parallel-group, placebo-controlled multicenter clinical trials included 754 adult patients being treated in a surgical intensive care unit. All patients were initially intubated and received mechanical ventilation. These trials evaluated the sedative properties of PRECEDEX by comparing the amount of rescue medication (midazolam in one trial and propofol in the second) required to achieve a specified level of sedation (using the standardized Ramsay Sedation Scale) between PRECEDEX and placebo from onset of treatment to extubation or to a total treatment duration of 24 hours. The Ramsay Level of Sedation Scale is displayed in <linkHtml href="#_RefTable12">Table 12</linkHtml>.</paragraph>
                        <table ID="_RefTable12" width="98%">
                           <caption>Table 12: Ramsay Level of Sedation Scale</caption>
                           <col width="24%"/>
                           <col width="76%"/>
                           <thead>
                              <tr>
                                 <th align="left" styleCode="Rrule Botrule Toprule " valign="top">
                                    <content styleCode="bold">Clinical Score</content>
                                 </th>
                                 <th align="left" styleCode="Botrule Lrule Toprule " valign="top">
                                    <content styleCode="bold">Level of Sedation Achieved</content>
                                 </th>
                              </tr>
                           </thead>
                           <tbody>
                              <tr>
                                 <td align="center" styleCode="Rrule Toprule Botrule " valign="middle">
                                    <paragraph>6</paragraph>
                                 </td>
                                 <td styleCode="Lrule Toprule Botrule " valign="middle">
                                    <paragraph>Asleep, no response</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Botrule " valign="middle">
                                    <paragraph>5</paragraph>
                                 </td>
                                 <td styleCode="Lrule Toprule Botrule " valign="middle">
                                    <paragraph>Asleep, sluggish response to light glabellar tap or loud auditory stimulus</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Botrule " valign="middle">
                                    <paragraph>4</paragraph>
                                 </td>
                                 <td styleCode="Lrule Toprule Botrule " valign="middle">
                                    <paragraph>Asleep, but with brisk response to light glabellar tap or loud auditory stimulus</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Botrule " valign="middle">
                                    <paragraph>3</paragraph>
                                 </td>
                                 <td styleCode="Lrule Toprule Botrule " valign="middle">
                                    <paragraph>Patient responds to commands</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Botrule " valign="middle">
                                    <paragraph>2</paragraph>
                                 </td>
                                 <td styleCode="Lrule Toprule Botrule " valign="middle">
                                    <paragraph>Patient cooperative, oriented, and tranquil</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Botrule Toprule " valign="middle">
                                    <paragraph>1</paragraph>
                                 </td>
                                 <td styleCode="Botrule Lrule Toprule " valign="middle">
                                    <paragraph>Patient anxious, agitated, or restless</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>In the first study, 175 adult patients were randomized to receive placebo and 178 to receive PRECEDEX by intravenous infusion at a dose of 0.4 mcg/kg/hr (with allowed adjustment between 0.2 and 0.7 mcg/kg/hr) following an initial loading infusion of one mcg/kg intravenous over 10 minutes. The study drug infusion rate was adjusted to maintain a Ramsay sedation score of ≥3. Patients were allowed to receive “rescue” midazolam as needed to augment the study drug infusion. In addition, morphine sulfate was administered for pain as needed. The primary outcome measure for this study was the total amount of rescue medication (midazolam) needed to maintain sedation as specified while intubated. Patients randomized to placebo received significantly more midazolam than patients randomized to PRECEDEX (see <linkHtml href="#_RefTable13">Table 13</linkHtml>).</paragraph>
                        <paragraph>A second prospective primary analysis assessed the sedative effects of PRECEDEX by comparing the percentage of adult patients who achieved a Ramsay sedation score of ≥3 during intubation without the use of additional rescue medication. A significantly greater percentage of adult patients in the PRECEDEX group maintained a Ramsay sedation score of ≥3 without receiving any midazolam rescue compared to the placebo group (see <linkHtml href="#table13">Table 13</linkHtml>).</paragraph>
                        <table width="98%">
                           <caption>Table 13: Midazolam Use as Rescue Medication During Intubation (ITT) Study One</caption>
                           <col width="40%"/>
                           <col width="22%"/>
                           <col width="20%"/>
                           <col width="18%"/>
                           <tfoot>
                              <tr>
                                 <td align="left" colspan="4" valign="top">ITT (intent-to-treat) population includes all randomized patients.</td>
                              </tr>
                           </tfoot>
                           <tbody>
                              <tr>
                                 <td styleCode="Rrule Botrule Toprule " valign="top"/>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Placebo</content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">(N = 175)</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">PRECEDEX</content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">(N = 178)</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule Lrule Toprule " valign="bottom">
                                    <paragraph>
                                       <content styleCode="bold">p-value</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Mean Total Dose (mg) of Midazolam</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule " valign="top">
                                    <paragraph>19 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule " valign="top">
                                    <paragraph>5 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule " valign="top">
                                    <paragraph>0.0011<footnote ID="_Ref114842623">ANOVA model with treatment center.</footnote>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Standard deviation</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>53 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>19 mg</paragraph>
                                 </td>
                                 <td styleCode="Lrule Botrule " valign="top"/>
                              </tr>
                              <tr>
                                 <td colspan="4" styleCode="Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Categorized Midazolam Use</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>0 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>43 (25%)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>108 (61%)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>&lt;0.001<footnote ID="_Ref114842645">Chi-square.</footnote>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule " valign="top">
                                    <paragraph>0–4 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule " valign="top">
                                    <paragraph>34 (19%)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule " valign="top">
                                    <paragraph>36 (20%)</paragraph>
                                 </td>
                                 <td styleCode="Lrule Toprule " valign="top"/>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Botrule Toprule " valign="top">
                                    <paragraph>&gt;4 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>98 (56%)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>34 (19%)</paragraph>
                                 </td>
                                 <td styleCode="Botrule Lrule Toprule " valign="top"/>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>A prospective secondary analysis assessed the dose of morphine sulfate administered to adult patients in the PRECEDEX and placebo groups. On average, PRECEDEX-treated patients received less morphine sulfate for pain than placebo-treated patients (0.47 versus 0.83 mg/h). In addition, 44% (79 of 178 patients) of PRECEDEX patients received no morphine sulfate for pain versus 19% (33 of 175 patients) in the placebo group.</paragraph>
                        <paragraph>In a second study, 198 adult patients were randomized to receive placebo and 203 to receive PRECEDEX by intravenous infusion at a dose of 0.4 mcg/kg/hr (with allowed adjustment between 0.2 and 0.7 mcg/kg/hr) following an initial loading infusion of one mcg/kg intravenous over 10 minutes. The study drug infusion was adjusted to maintain a Ramsay sedation score of ≥3. Patients were allowed to receive “rescue” propofol as needed to augment the study drug infusion. In addition, morphine sulfate was administered as needed for pain. The primary outcome measure for this study was the total amount of rescue medication (propofol) needed to maintain sedation as specified while intubated.</paragraph>
                        <paragraph>Adult patients randomized to placebo received significantly more propofol than adult patients randomized to PRECEDEX (see <linkHtml href="#_Ref115198292">Table 14</linkHtml>).</paragraph>
                        <paragraph>A significantly greater percentage of adult patients in the PRECEDEX group compared to the placebo group maintained a Ramsay sedation score of ≥3 without receiving any propofol rescue (see <linkHtml href="#_Ref115198292">Table 14</linkHtml>).</paragraph>
                        <table ID="_Ref115198292" width="98%">
                           <caption>Table 14: Propofol Use as Rescue Medication During Intubation (ITT) Study Two</caption>
                           <col width="36%"/>
                           <col width="21%"/>
                           <col width="23%"/>
                           <col width="21%"/>
                           <thead>
                              <tr>
                                 <th align="left" styleCode="Rrule Botrule Toprule " valign="top"/>
                                 <th align="center" styleCode="Rrule Botrule Toprule " valign="top">
                                    <content styleCode="bold">Placebo</content>
                                    <br/>
                                    <content styleCode="bold"> (N = 198)</content>
                                 </th>
                                 <th align="center" styleCode="Rrule Botrule Toprule " valign="top">
                                    <content styleCode="bold">PRECEDEX</content>
                                    <br/>
                                    <content styleCode="bold"> (N = 203)</content>
                                 </th>
                                 <th align="center" styleCode="Botrule Toprule " valign="bottom">
                                    <content styleCode="bold">p-value</content>
                                 </th>
                              </tr>
                           </thead>
                           <tbody>
                              <tr>
                                 <td styleCode="Rrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Mean Total Dose (mg) of Propofol</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Toprule " valign="top">
                                    <paragraph>513 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Toprule " valign="top">
                                    <paragraph>72 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Toprule " valign="top">
                                    <paragraph>&lt;0.0001<footnote ID="_Ref114842679">ANOVA model with treatment center.</footnote>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Standard deviation</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>782 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>249 mg</paragraph>
                                 </td>
                                 <td styleCode="Botrule " valign="top"/>
                              </tr>
                              <tr>
                                 <td colspan="4" styleCode="Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Categorized Propofol Use</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>0 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>47 (24%)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>122 (60%)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule " valign="top">
                                    <paragraph>&lt;0.001<footnote ID="_Ref114842699">Chi-square.</footnote>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>0–50 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>30 (15%)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>43 (21%)</paragraph>
                                 </td>
                                 <td styleCode="Botrule " valign="top"/>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>&gt;50 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>121 (61%)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>38 (19%)</paragraph>
                                 </td>
                                 <td styleCode="Botrule " valign="top"/>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>A prospective secondary analysis assessed the dose of morphine sulfate administered to adult patients in the PRECEDEX and placebo groups. On average, PRECEDEX-treated patients received less morphine sulfate for pain than placebo-treated patients (0.43 versus 0.89 mg/h). In addition, 41% (83 of 203 patients) of PRECEDEX patients received no morphine sulfate for pain versus 15% (30 of 198 patients) in the placebo group.</paragraph>
                        <paragraph>In a controlled clinical trial, PRECEDEX was compared to midazolam for ICU sedation exceeding 24 hours duration. PRECEDEX was not shown to be superior to midazolam for the primary efficacy endpoint, the percent of time patients were adequately sedated (81% versus 81%). In addition, administration of PRECEDEX for longer than 24 hours was associated with tolerance, tachyphylaxis, and a dose-related increase in adverse events <content styleCode="italics">[see <linkHtml href="#ID_b91b0be6-1ca3-468d-a2fe-c3f1e6176758">Adverse Reactions (6.1)</linkHtml>]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20221212"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_141e5ed6-497d-4a32-81d1-caccfe8ecb04">
                     <id root="d9a165ee-f061-4724-b5f9-322556bc4d98"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>14.2	Procedural Sedation </title>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Adult Patients</content>
                        </paragraph>
                        <paragraph>The safety and efficacy of PRECEDEX for sedation of non-intubated adult patients prior to and/or during surgical and other procedures was evaluated in two randomized, double-blind, placebo-controlled multicenter clinical trials. Study 1 evaluated the sedative properties of PRECEDEX in adult patients having a variety of elective surgeries/procedures performed under monitored anesthesia care. Study 2 evaluated PRECEDEX in adult patients undergoing awake fiberoptic intubation prior to a surgical or diagnostic procedure.</paragraph>
                        <paragraph>In Study 1, the sedative properties of PRECEDEX were evaluated by comparing the percent of adult patients not requiring rescue midazolam to achieve a specified level of sedation using the standardized Observer’s Assessment of Alertness/Sedation Scale (see <linkHtml href="#_RefTable15">Table 15</linkHtml>).</paragraph>
                        <table ID="_RefTable15" width="98%">
                           <caption>Table 15: Observer’s Assessment of Alertness/Sedation</caption>
                           <col width="26%"/>
                           <col width="19%"/>
                           <col width="19%"/>
                           <col width="18%"/>
                           <col width="18%"/>
                           <thead>
                              <tr>
                                 <th align="center" colspan="5" styleCode="Botrule Toprule " valign="top">
                                    <content styleCode="bold">Assessment Categories</content>
                                 </th>
                              </tr>
                              <tr>
                                 <th align="left" styleCode="Rrule Botrule " valign="bottom">
                                    <content styleCode="bold">Responsiveness</content>
                                 </th>
                                 <th align="center" styleCode="Rrule Botrule " valign="bottom">
                                    <content styleCode="bold">Speech</content>
                                 </th>
                                 <th align="center" styleCode="Rrule Botrule " valign="bottom">
                                    <content styleCode="bold">Facial Expression</content>
                                 </th>
                                 <th align="center" styleCode="Rrule Botrule " valign="bottom">
                                    <content styleCode="bold">Eyes</content>
                                 </th>
                                 <th align="center" styleCode="Botrule " valign="bottom">
                                    <content styleCode="bold">Composite Score</content>
                                 </th>
                              </tr>
                           </thead>
                           <tbody>
                              <tr>
                                 <td styleCode="Rrule Toprule Botrule " valign="top">
                                    <paragraph>Responds readily to name spoken in normal tone</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Toprule Botrule " valign="top">
                                    <paragraph>Normal</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Toprule Botrule " valign="top">
                                    <paragraph>Normal</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Toprule Botrule " valign="top">
                                    <paragraph>Clear, no ptosis</paragraph>
                                 </td>
                                 <td align="center" styleCode="Toprule Botrule " valign="top">
                                    <paragraph>5 (alert)</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Lethargic response to name spoken in normal tone</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Mild slowing or thickening</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Mild relaxation</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Glazed or mild ptosis (less than half the eye)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule " valign="top">
                                    <paragraph>4</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Responds only after name is called loudly and/or repeatedly</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Slurring or prominent slowing</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Marked relaxation<br/>(slack jaw)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Glazed and marked ptosis (half the eye or more)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule " valign="top">
                                    <paragraph>3</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Responds only after mild prodding or shaking</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Few recognizable words</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="middle">
                                    <paragraph>–</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="middle">
                                    <paragraph>–</paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule " valign="top">
                                    <paragraph>2</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Does not respond to mild prodding or shaking</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="middle">
                                    <paragraph>–</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="middle">
                                    <paragraph>–</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="middle">
                                    <paragraph>–</paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule " valign="top">
                                    <paragraph>1 (deep sleep)</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>Adult patients were randomized to receive a loading infusion of either PRECEDEX 1 mcg/kg, PRECEDEX 0.5 mcg/kg, or placebo (normal saline) given over 10 minutes and followed by a maintenance infusion started at 0.6 mcg/kg/hr. The maintenance infusion of study drug could be titrated from 0.2 mcg/kg/hr to 1 mcg/kg/hr to achieve the targeted sedation score (Observer’s Assessment of Alertness/Sedation Scale ≤4). Adult patients were allowed to receive rescue midazolam as needed to achieve and/or maintain an Observer’s Assessment of Alertness/Sedation Scale ≤4. After achieving the desired level of sedation, a local or regional anesthetic block was performed. Demographic characteristics were similar between the PRECEDEX and comparator groups. Efficacy results showed that PRECEDEX was more effective than the comparator group when used to sedate non-intubated patients requiring monitored anesthesia care during surgical and other procedures (see <linkHtml href="#_RefTable15">Table 15</linkHtml>).</paragraph>
                        <paragraph>In Study 2, the sedative properties of PRECEDEX were evaluated by comparing the percent of adult patients requiring rescue midazolam to achieve or maintain a specified level of sedation using the Ramsay Sedation Scale score ≥2 (see <linkHtml href="#_RefTable12">Table 12</linkHtml>). Adult patients were randomized to receive a loading infusion of PRECEDEX 1 mcg/kg or placebo (normal saline) given over 10 minutes and followed by a fixed maintenance infusion of 0.7 mcg/kg/hr. After achieving the desired level of sedation, topicalization of the airway occurred. Adult patients were allowed to receive rescue midazolam as needed to achieve and/or maintain a Ramsay Sedation Scale ≥2. Demographic characteristics were similar between the PRECEDEX and comparator groups. For efficacy results see <linkHtml href="#_RefTable16">Table 16</linkHtml>.</paragraph>
                        <table ID="_RefTable16" width="99.02%">
                           <caption>Table 16: Key Efficacy Results of Adult Procedural Sedation Studies</caption>
                           <col width="9%"/>
                           <col width="18%"/>
                           <col width="17%"/>
                           <col width="13%"/>
                           <col width="14%"/>
                           <col width="14%"/>
                           <col width="14%"/>
                           <tbody>
                              <tr>
                                 <td styleCode="Rrule Botrule Toprule " valign="middle">
                                    <paragraph>
                                       <content styleCode="bold">Study</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="bottom">
                                    <paragraph>
                                       <content styleCode="bold">Loading Infusion Treatment Arm</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="bottom">
                                    <paragraph>
                                       <content styleCode="bold">Number of Patients Enrolled</content>
                                       <footnote ID="_Ref114842952">Based on ITT population defined as all randomized and treated patients.</footnote>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="bottom">
                                    <paragraph>
                                       <content styleCode="bold">% Not Requiring Midazolam Rescue</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="bottom">
                                    <paragraph>
                                       <content styleCode="bold">Confidence</content>
                                       <footnote ID="_Ref114842784">Normal approximation to the binomial with continuity correction.</footnote>
                                       <content styleCode="bold"> Interval on the Difference vs. Placebo</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Mean (SD) Total Dose (mg) of Rescue Midazolam Required</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule Lrule Toprule " valign="bottom">
                                    <paragraph>
                                       <content styleCode="bold">Confidence</content>
                                       <footnoteRef IDREF="_Ref114842784"/>
                                       <content styleCode="bold"> Intervals of the Mean Rescue Dose</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td rowspan="3" styleCode="Rrule Toprule Botrule " valign="middle">
                                    <paragraph>
                                       <content styleCode="bold">Study 1</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Dexmedetomidine 0.5 mcg/kg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>134</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>40</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>37 (27, 48)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>1.4 (1.7)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="middle">
                                    <paragraph>-2.7</paragraph>
                                    <paragraph>(-3.4, -2.0)</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Dexmedetomidine 1 mcg/kg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>129</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>54</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>51 (40, 62)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.9 (1.5)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>-3.1</paragraph>
                                    <paragraph>(-3.8, -2.5)</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Placebo</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>63</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>–</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>4.1 (3.0)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>–</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td rowspan="2" styleCode="Rrule Toprule Botrule " valign="middle">
                                    <paragraph>
                                       <content styleCode="bold">Study 2</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Dexmedetomidine 1 mcg/kg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>55</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>53</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>39 (20, 57)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>1.1 (1.5)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Lrule Toprule Botrule " valign="top">
                                    <paragraph>-1.8</paragraph>
                                    <paragraph>(-2.7, -0.9)</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>Placebo</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>50</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>14</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>–</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>2.9 (3.0)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Botrule Lrule Toprule " valign="top">
                                    <paragraph>–</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>
                           <content styleCode="underline">Pediatric Patients</content>
                        </paragraph>
                        <paragraph>The safety and efficacy of PRECEDEX for sedation of non-intubated pediatric patients aged 1 month to less than 17 years undergoing MRI scans was evaluated in one randomized, double-blind, dose-ranging, dose‑controlled multicenter clinical trial utilizing 3 different PRECEDEX dosages. The sedative properties of PRECEDEX were evaluated by age group and by the percent of pediatric patients at the high dose level versus the low dose level who did not require concomitant propofol to complete the MRI scan. </paragraph>
                        <paragraph>A total of 122 pediatric patients were randomized to the PRECEDEX low dose group (42 of 122), the middle dose group (42 of 122) or the high dose treatment group (38 of 122). All patients received a PRECEDEX loading dose infusion over 10 minutes followed by a maintenance infusion for the duration of the MRI scan (<linkHtml href="#_RefTable17">Table 17</linkHtml>). If an adequate level of sedation was not achieved within 5 minutes after the start of the PRECEDEX maintenance infusion, patients could receive concomitant propofol as needed based on clinical judgment to achieve and/or maintain adequate sedation.</paragraph>
                        <table ID="_RefTable17" width="97.8%">
                           <caption>Table 17: PRECEDEX Loading and Maintenance Doses</caption>
                           <col width="15%"/>
                           <col width="13%"/>
                           <col width="16%"/>
                           <col width="13%"/>
                           <col width="15%"/>
                           <col width="13%"/>
                           <col width="15%"/>
                           <tbody>
                              <tr>
                                 <td styleCode="Rrule Lrule Toprule " valign="top"/>
                                 <td align="center" colspan="2" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">High Dose</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" colspan="2" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Middle Dose</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" colspan="2" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Low Dose</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Age </content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Loading Dose </content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">(10 min)</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Maintenance Dose</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Loading Dose </content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">(10 min)</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Maintenance Dose</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Loading Dose </content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">(10 min)</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Maintenance Dose</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>1 month to less than 2 years</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>1.5 mcg/kg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>1.5 mcg/kg/h</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>1 mcg/kg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>1 mcg/kg/h</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>0.5 mcg/kg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>0.5 mcg/kg/h</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>2 to less than 17 years</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Toprule " valign="top">
                                    <paragraph>2 mcg/kg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>1.5 mcg/kg/h</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>1.2 mcg /kg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>1 mcg/kg/h</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>0.5 mcg/kg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>0.5 mcg kg/h</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>The primary efficacy results from this pediatric procedural sedation study are summarized in <linkHtml href="#_RefTable18">Table 18</linkHtml>. In the combined age group, the percent of pediatric patients not requiring concomitant propofol was 14.3% (6/42) in the low dose group and 63.2% (24/38) in the high dose group. The percentage of patients at the PRECEDEX high dose who completed the MRI without concomitant propofol was statistically greater than the percentage in the PRECEDEX low dose group (p&lt;0.001).</paragraph>
                        <table ID="_RefTable18" width="97.8%">
                           <caption>Table 18: Percent of Pediatric Patients not Requiring Concomitant Propofol by Age Group and Overall</caption>
                           <col width="16%"/>
                           <col width="11%"/>
                           <col width="14%"/>
                           <col width="14%"/>
                           <col width="14%"/>
                           <col width="17%"/>
                           <col width="15%"/>
                           <tbody>
                              <tr styleCode="Toprule">
                                 <td styleCode="Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Age Group</content>
                                    </paragraph>
                                 </td>
                                 <td styleCode="Rrule Toprule " valign="top"/>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">High Dose</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Middle Dose</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Low Dose</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" colspan="2" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">High Dose vs Low Dose</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Lrule Botrule " valign="top"/>
                                 <td valign="top"/>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">n (%)</content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">95% CI</content>
                                       <footnote ID="_Ref126342116">Exact 95% CI of proportion of subjects not requiring propofol in each dose level.</footnote>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">n (%)</content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">95% CI</content>
                                       <footnoteRef IDREF="_Ref126342116"/>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">n (%)</content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">95% CI</content>
                                       <footnoteRef IDREF="_Ref126342116"/>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Odds Ratio</content>
                                    </paragraph>
                                    <paragraph>
                                       <content styleCode="bold">95% CI</content>
                                       <footnote ID="_Ref126342179">p-values; CI is confidence interval of odds ratio.</footnote>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">p-value</content>
                                       <footnoteRef IDREF="_Ref126342179"/>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>1 month to less than 2 years</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>N=59</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>9/18 (50.0%)</paragraph>
                                    <paragraph>(0.26, 0.74)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2/21 (9.5%)</paragraph>
                                    <paragraph>(0.01, 0.30)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>2/20 (15.0%)</paragraph>
                                    <paragraph>(0.03, 0.38)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.18 (0.04, 0.82)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.022</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>2 to less than 17 years</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>N=63</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>15/20 (75.0%)</paragraph>
                                    <paragraph>(0.51, 0.91)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>13/21 (61.9%)</paragraph>
                                    <paragraph>(0.38, 0.82)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3/22 (13.6%)</paragraph>
                                    <paragraph>(0.03, 0.35)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.05 (0.01, 0.26)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>&lt;0.001</paragraph>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Overall</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>N=122</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>24/38 (63.2%)</paragraph>
                                    <paragraph>(0.46, 0.78)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>15/42 (35.7%)</paragraph>
                                    <paragraph>(0.22, 0.52)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>6/42 (14.3%)</paragraph>
                                    <paragraph>(0.05, 0.29)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>0.10 (0.03, 0.29)</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>&lt;0.001</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>Secondarily, the sedative properties were also evaluated by examining the percent of time at a target sedation score using the Pediatric Sedation State Scale (PSSS). The PSSS is a validated 6-point scale specifically designed for evaluating pediatric patients undergoing sedation for diagnostic and therapeutic procedures. The PSSS measures the effectiveness and quality of procedural sedation in children. The target sedation level was indicated by a PSSS score of 2 (i.e., patient is quiet [asleep or awake], not moving during procedure, has no frown [or brow furrow] indicating pain or anxiety and no verbalization of any complaint).</paragraph>
                        <paragraph>In the PRECEDEX high dose group, pediatric patients in both the combined and individual age group were at the target sedation rating scale score (PSSS of 2) for a mean &gt;87% of the time during the PRECEDEX maintenance infusion. In both the combined and individual age group, an increase in the percentage of time at the target sedation rating scale score (PSSS of 2) was observed with increasing PRECEDEX dosage.</paragraph>
                     </text>
                     <effectiveTime value="20221212"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_924FD068-57A9-4670-A773-9AD918B708D7">
               <id root="54b4b67f-004d-4a1c-8737-099f353e0113"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title>16 HOW SUPPLIED/STORAGE AND HANDLING </title>
               <text>
                  <paragraph>Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F). [See USP Controlled Room Temperature.]</paragraph>
                  <paragraph>Do not use if product is discolored or if precipitate matter is present.</paragraph>
                  <paragraph>PRECEDEX (dexmedetomidine hydrochloride in 0.9% Sodium Chloride) injection (4 mcg/mL) is clear and colorless. The strength is based on the dexmedetomidine base. Discard unused portion.</paragraph>
                  <table width="98%">
                     <col width="49%"/>
                     <col width="51%"/>
                     <tbody>
                        <tr styleCode="Toprule">
                           <td styleCode="Rrule Botrule Lrule Toprule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Unit of Sale</content>
                              </paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Concentration</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">NDC 0409-4596-20</content>
                              </paragraph>
                              <paragraph>Tray of 20 single‑dose clear glass bottles</paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <paragraph>200 mcg/50 mL</paragraph>
                              <paragraph>(4 mcg/mL)</paragraph>
                           </td>
                        </tr>
                        <tr styleCode="Botrule">
                           <td styleCode="Rrule Botrule Lrule Toprule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">NDC 0409-0155-02</content>
                              </paragraph>
                              <paragraph>Tray of 10 single‑dose clear glass bottles</paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                              <paragraph>400 mcg/100 mL</paragraph>
                              <paragraph>(4 mcg/mL)</paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
               </text>
               <effectiveTime value="20221212"/>
            </section>
         </component>
         <component>
            <section ID="ID_8E6BEB99-0320-41CC-8EAF-48D5788341E9">
               <id root="b81f9091-3265-4061-8f06-1bb337651367"/>
               <code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="INFORMATION FOR PATIENTS SECTION"/>
               <title>17 PATIENT COUNSELING INFORMATION </title>
               <text>
                  <paragraph>PRECEDEX is indicated for short-term intravenous sedation. Dosage must be individualized and titrated to the desired clinical effect. Blood pressure, heart rate and oxygen levels will be monitored both continuously during the infusion of PRECEDEX and as clinically appropriate after discontinuation.</paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>•</caption>When PRECEDEX is infused for more than 6 hours, patients should be informed to report nervousness, agitation, and headaches that may occur for up to 48 hours.</item>
                     <item>
                        <caption>•</caption>Additionally, patients should be informed to report symptoms that may occur within 48 hours after the administration of PRECEDEX such as: weakness, confusion, excessive sweating, weight loss, abdominal pain, salt cravings, diarrhea, constipation, dizziness or light-headedness.</item>
                     <item>
                        <caption>•</caption>Advise breastfeeding mothers who were exposed to PRECEDEX to monitor breastfed neonates for irritability <content styleCode="italics">[see <linkHtml href="#ID_5D9FB002-5996-4EC7-BECC-89F13C00E58E">Use in Specific Populations (8.2)</linkHtml>]</content>.</item>
                  </list>
                  <paragraph>Distributed by Hospira, Inc. Lake Forest, IL 60045</paragraph>
                  <renderMultiMedia ID="id577183666" referencedObject="ID_9d72a3a4-c3de-47f3-865a-6f26e0d8393e"/>
                  <paragraph>PREMIERProRx<sup>®</sup> is a registered trademark of Premier Healthcare Alliance, L.P., used under license.</paragraph>
                  <paragraph>LAB-1531-2.0</paragraph>
               </text>
               <effectiveTime value="20221212"/>
               <component>
                  <observationMedia ID="ID_9d72a3a4-c3de-47f3-865a-6f26e0d8393e">
                     <text>PremierProRx logo</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="precedex2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_60635b97-4df2-4945-92a4-b44a3cf9777b">
               <id root="121e6b6d-7846-49a6-9c04-6f43b4825026"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 50 mL Bottle Label</title>
               <text>
                  <paragraph>50 mL<br/>Rx only<br/>NDC 0409-4596-01</paragraph>
                  <paragraph>Single-dose bottle. Discard unused portion.</paragraph>
                  <paragraph>Precedex™<br/>Dexmedetomidine HCl<br/>in 0.9% Sodium Chloride<br/>Injection</paragraph>
                  <paragraph>200 mcg/50 mL<br/>(4 mcg/mL)</paragraph>
                  <paragraph>For Intravenous Use</paragraph>
                  <renderMultiMedia ID="id2683" referencedObject="MM3"/>
               </text>
               <effectiveTime value="20230103"/>
               <component>
                  <observationMedia ID="MM3">
                     <text>PRINCIPAL DISPLAY PANEL - 50 mL Bottle Label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="precedex-03.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_c685821b-0be7-4d6d-a4c7-65efbf01873d">
               <id root="cafaaafa-5ca7-4abd-a634-74850192ca90"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 50 mL Bottle Tray</title>
               <text>
                  <paragraph>20 Units X 50 mL<br/>Rx only<br/>NDC 0409-4596-20</paragraph>
                  <paragraph>Single-dose bottle. Discard unused portion.<br/>Contains 20 of NDC 0409-4596-01</paragraph>
                  <paragraph>Precedex™<br/>Dexmedetomidine HCl<br/>in 0.9% Sodium Chloride Injection</paragraph>
                  <paragraph>200 mcg/50 mL<br/>(4 mcg/mL)</paragraph>
                  <paragraph>For Intravenous Use</paragraph>
                  <renderMultiMedia ID="id2710" referencedObject="MM4"/>
               </text>
               <effectiveTime value="20230103"/>
               <component>
                  <observationMedia ID="MM4">
                     <text>PRINCIPAL DISPLAY PANEL - 50 mL Bottle Tray</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="precedex-04.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_e55e3b0d-f616-4eed-b12a-d90dd2149acb">
               <id root="7142f34e-5d8a-411d-828c-cdef3ddfbc51"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 100 mL Bottle Label</title>
               <text>
                  <paragraph>100 mL<br/>Rx only<br/>NDC 0409-0155-01</paragraph>
                  <paragraph>Single-dose bottle. Discard unused portion.</paragraph>
                  <paragraph>Precedex™<br/>Dexmedetomidine HCl<br/>in 0.9% Sodium Chloride<br/>Injection</paragraph>
                  <paragraph>400 mcg/100 mL<br/>(4 mcg/mL)</paragraph>
                  <paragraph>For Intravenous Use</paragraph>
                  <renderMultiMedia ID="id2784" referencedObject="MM7"/>
               </text>
               <effectiveTime value="20221212"/>
               <component>
                  <observationMedia ID="MM7">
                     <text>PRINCIPAL DISPLAY PANEL - 100 mL Bottle Label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="precedex-05.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_6abc3382-70df-4c5d-b93e-167dcd76b862">
               <id root="94b5c40a-3a60-4c05-be8f-5f6dd57b7f2e"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 100 mL Bottle Tray</title>
               <text>
                  <paragraph>10 Units X 100 mL<br/>Rx only<br/>NDC 0409-0155-02<br/>Contains 10 of NDC 0409-0155-01</paragraph>
                  <paragraph>Single-dose bottle. Discard unused portion.</paragraph>
                  <paragraph>Precedex™<br/>Dexmedetomidine HCl<br/>in 0.9% Sodium Chloride<br/>Injection</paragraph>
                  <paragraph>400 mcg/100 mL<br/>(4 mcg/mL)</paragraph>
                  <paragraph>For Intravenous Use</paragraph>
                  <renderMultiMedia ID="id2811" referencedObject="MM8"/>
               </text>
               <effectiveTime value="20221212"/>
               <component>
                  <observationMedia ID="MM8">
                     <text>PRINCIPAL DISPLAY PANEL - 100 mL Bottle Tray</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="precedex-06.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>